Non-covalent modification of graphene-based chemical sensors
A graphene-based chemical sensor with a non-covalently bonded self-assembled monolayer enhances VOC detection sensitivity, facilitating early disease identification through breath analysis.
Patent Information
- Application Number
- JP2022511117
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2019-08-20
- Filing Date
- 2020-08-18
- Publication Date
- 2024-11-29
- Estimated Expiration
- 2040-08-18
AI Technical Summary
Existing chemical sensors lack the sensitivity and specificity to accurately detect volatile organic compounds (VOCs) associated with diseases at early stages, limiting timely therapeutic interventions.
A graphene-based chemical sensor with a self-assembled monolayer on its surface, composed of molecules like pyrenes, calixarenes, or peralkylated cyclodextrins, that interact non-covalently with graphene, enhancing sensitivity to detect VOCs at parts per billion or parts per million levels.
The sensor provides high sensitivity and specificity for VOC detection, enabling early identification of diseases such as cancer, heart disease, and neurological disorders by analyzing breath samples.
Smart Images

Figure 0007592070000045 
Figure 0007592070000046 
Figure 0007592070000047
Abstract
Description
[Technical field]
[0001] This application was filed on August 18, 2020 as a PCT international patent application in the name of Boston Scientific Simulated, Inc., a U.S. corporation, as applicant designating all countries, and Xue Zhen, a citizen of the People's Republic of China, as inventor designating all countries. This application has also been filed as a PCT international patent application in the name of the Regents of the University of Minnesota, as applicant designating all countries, and Philippe Pierre Joseph Buhlmann, a U.S. citizen, and Steven J. Koester, a U.S. citizen, as inventor designating all countries. This application claims priority to U.S. Provisional Patent Application No. 62 / 889,387, filed on August 20, 2019, the contents of which are incorporated herein by reference in their entirety.
[0002] Field FIELD OF THE DISCLOSURE Embodiments herein relate to chemical sensors, instruments and systems including chemical sensors, and related methods. More particularly, embodiments herein relate to chemical sensors based on non-covalent surface modification of graphene. [Background technology]
[0003] Accurate detection of disease allows clinicians to make appropriate therapeutic interventions. Early detection of disease may result in better treatment outcomes. Disease can be detected using many different techniques, including analysis of tissue samples, analysis of various body fluids, diagnostic scans, genetic analysis, etc.
[0004] Some pathological conditions result in the production of specific compounds. In some cases, volatile organic compounds (VOCs) released in a patient's gaseous sample can be characteristic of a particular disease. The detection of these compounds or their differential detection can allow for the early detection of certain pathological conditions. Summary of the Invention
[0005] In a first aspect, a medical device is included having a graphene varactor, the graphene varactor comprising a graphene layer and a self-assembled monolayer, the self-assembled monolayer disposed on an outer surface of the graphene layer through non-covalent interactions between the self-assembled monolayer and the pi-electron system of graphene. The self-assembled monolayer can include one or more pillarenes, substituted pillarenes, calixarenes, substituted calixarenes, peralkylated cyclodextrins, substituted peralkylated cyclodextrins, pyrenes or substituted pyrenes, or derivatives thereof.
[0006] In a second embodiment, in addition to one or more of the preceding or following embodiments, or as an alternative to certain embodiments, the self-assembled monolayer provides a Langmuir theta value of at least 0.9.
[0007] In a third aspect, in addition to one or more of the preceding or following aspects, or as an alternative to certain aspects, the self-assembled monolayer provides a Langmuir theta value of at least 0.98.
[0008] In a fourth aspect, in addition to one or more of the previous or following aspects, or as an alternative to some aspects, the self-assembled monolayer provides a coverage on the graphene of between 50% and 150% by surface area.
[0009] In a fifth aspect, in addition to one or more of the preceding or following aspects, or as an alternative to some aspects, a plurality of graphene varactors arranged in an array on the medical device may be included.
[0010] In a sixth embodiment, in addition to one or more of the preceding or following embodiments, or as an alternative to some embodiments, the self-assembled monolayer has the formula: JPEG0007592070000001.jpg50170
[0011] and In the formula, each R 0 are independent of each other, -R 1 , -OR 1 or -SR 1 Each R 1 are independently H; -OH; =O; any linear, branched or cyclic C1-C 20 Alkyl, C1-C 20 Alkenyl, C1-C 20 Alkynyl, C1-C 20 Heteroalkyl, C1-C 20 Heteroalkenyl, C1-C 20 Heteroalkynyl, C1-C 20 Haloalkyl groups, C1-C 20 Haloalkenyl groups, C1-C 20 Haloalkynyl groups, C1-C 20 Halogenated heteroalkyl groups, C1-C 20 Halogenated heteroalkenyl groups, C1-C 20 a halogenated heteroalkynyl group, or any combination thereof; an aryl, a heteroaryl, a substituted aryl, a substituted heteroarylaryl, an aryl halide, a substituted aryl halide, a benzyl or substituted benzyl, a biphenyl or substituted biphenyl, an aryloxy, an arylthio, an arylamine, or any substituted form thereof; -R 2 OH, -R 2 C(O)OH, -R 2 C(O)OR 2 , -R 2 OR 2 , -R 2 S.R. 2 , -R 2 CHO, -R 2 X (wherein X is a halogen atom), -R 2 C(O)NH2, -R 2 C(O)NR 2 , -R 2 NH3 + , -R 2 NH2, -R 2NO2, -R 2 NHR 2 , -R 2 NR 2 R 2 , -R 2 N3, -R 2 OPO(OH)2, -R 2 OSO(OH)2, or any derivative or combination thereof, and each R 2 are independently any identical or different linear, branched or cyclic C1-C 20 Alkyl, C1-C 20 Alkenyl, C1-C 20 Alkynyl, C1-C 20 Heteroalkyl, C1-C 20 Heteroalkenyl, C1-C 20 Heteroalkynyl, C1-C 20 Haloalkyl groups, C1-C 20 Haloalkenyl groups, C1-C 20 Haloalkynyl groups, C1-C 20 Halogenated heteroalkyl groups, C1-C 20 Halogenated heteroalkenyl groups, C1-C 20 halogenated heteroalkynyl groups, or any substituted or combined form thereof, where n is an integer of at least 5-15.
[0012] In a seventh aspect, in addition to one or more of the preceding or following aspects, or as an alternative to some aspects, R 0 At least some of the substituents are other R 0 Different from the substituent.
[0013] In an eighth embodiment, in addition to one or more of the preceding or following embodiments, or as an alternative to some embodiments, the self-assembled monolayer has the formula: JPEG0007592070000002.jpg52170
[0014] and In the formula, each R 0 are independent of each other, -R 1 , -OR1 or -SR 1 Each R 1 are independently H; -OH; =O; any linear, branched or cyclic C1-C 20 Alkyl, C1-C 20 Alkenyl, C1-C 20 Alkynyl, C1-C 20 Heteroalkyl, C1-C 20 Heteroalkenyl, C1-C 20 Heteroalkynyl, C1-C 20 Haloalkyl groups, C1-C 20 Haloalkenyl groups, C1-C 20 Haloalkynyl groups, C1-C 20 Halogenated heteroalkyl groups, C1-C 20 Halogenated heteroalkenyl groups, C1-C 20 a halogenated heteroalkynyl group, or any combination thereof; an aryl, a heteroaryl, a substituted aryl, a substituted heteroarylaryl, an aryl halide, a substituted aryl halide, a benzyl or substituted benzyl, a biphenyl or substituted biphenyl, an aryloxy, an arylthio, an arylamine, or any substituted form thereof; -R 2 OH, -R 2 C(O)OH, -R 2 C(O)OR 2 , -R 2 OR 2 , -R 2 S.R. 2 , -R 2 CHO, -R 2 X (wherein X is a halogen atom), -R 2 C(O)NH2, -R 2 C(O)NR 2 , -R 2 NH3 + , -R 2 NH2, -R 2 NO2, -R 2 NHR 2 , -R 2 NR 2 R 2 , -R 2 N3, -R 2 OPO(OH)2, -R 2OSO(OH)2, or any derivative or combination thereof, and each R 2 are independently any identical or different linear, branched or cyclic C1-C 20 Alkyl, C1-C 20 Alkenyl, C1-C 20 Alkynyl, C1-C 20 Heteroalkyl, C1-C 20 Heteroalkenyl, C1-C 20 Heteroalkynyl, C1-C 20 Haloalkyl groups, C1-C 20 Haloalkenyl groups, C1-C 20 Haloalkynyl groups, C1-C 20 Halogenated heteroalkyl groups, C1-C 20 Halogenated heteroalkenyl groups, C1-C 20 halogenated heteroalkynyl groups, or any substituted or combined form thereof, where x is an integer of at least 0-15, y is an integer of at least 0-15, and n is an integer of at least 5-15.
[0015] In a ninth aspect, in addition to one or more of the preceding or following aspects, or as an alternative to some aspects, the self-assembled monolayer comprises: JPEG0007592070000003.jpg60170
[0016] JPEG0007592070000004.jpg63170
[0017] or JPEG0007592070000005.jpg62170
[0018] and wherein the calixarene may have any of the following formulas: In the formula, each R 0 are independent of each other, -R 1 , -OR 1 or -SR 1 Each R 1are independently H; -OH; any linear, branched or cyclic C1-C 20 Alkyl, C1-C 20 Alkenyl, C1-C 20 Alkynyl, C1-C 20 Heteroalkyl, C1-C 20 Heteroalkenyl, C1-C 20 Heteroalkynyl, C1-C 20 Haloalkyl groups, C1-C 20 Haloalkenyl groups, C1-C 20 Haloalkynyl groups, C1-C 20 Halogenated heteroalkyl groups, C1-C 20 Halogenated heteroalkenyl groups, C1-C 20 a halogenated heteroalkynyl group, or any combination thereof; an aryl, a heteroaryl, a substituted aryl, a substituted heteroarylaryl, an aryl halide, a substituted aryl halide, a biphenyl or a substituted biphenyl, an aryloxy, an arylthio, an arylamine, or any substituted form thereof; -R 2 OH, -R 2 C(O)OH, -R 2 C(O)OR 2 , -R 2 OR 2 , -R 2 S.R. 2 , -R 2 CHO, -R 2 X (wherein X is a halogen atom), -R 2 C(O)NH2, -R 2 C(O)NR 2 , -R 2 NH3 + , -R 2 NH2, -R 2 NO2, -R 2 NHR 2 , -R 2 NR 2 R 2 , -R 2 N3, -R 2 OPO(OH)2, -R 2 OSO(OH)2, or any derivative or combination thereof, and each R 2are independently any identical or different linear, branched or cyclic C1-C 20 Alkyl, C1-C 20 Alkenyl, C1-C 20 Alkynyl, C1-C 20 Heteroalkyl, C1-C 20 Heteroalkenyl, C1-C 20 Heteroalkynyl, C1-C 20 Haloalkyl groups, C1-C 20 Haloalkenyl groups, C1-C 20 Haloalkynyl groups, C1-C 20 Halogenated heteroalkyl groups, C1-C 20 Halogenated heteroalkenyl groups, C1-C 20 halogenated heteroalkynyl groups, or any substituted or combined form thereof, where n is an integer of at least 3-15.
[0019] In a tenth aspect, in addition to one or more of the preceding or following aspects, or as an alternative to certain aspects, the self-assembled monolayer has the formula: JPEG0007592070000006.jpg42170
[0020] and wherein each Z can independently include -S or -O, and each R 1 are independently H; -OH; any linear, branched or cyclic C1-C 20 Alkyl, C1-C 20 Alkenyl, C1-C 20 Alkynyl, C1-C 20 Heteroalkyl, C1-C 20 Heteroalkenyl, C1-C 20 Heteroalkynyl, C1-C 20 Haloalkyl groups, C1-C 20 Haloalkenyl groups, C1-C 20 Haloalkynyl groups, C1-C 20 Halogenated heteroalkyl groups, C1-C 20 Halogenated heteroalkenyl groups, C1-C 20a halogenated heteroalkynyl group, or any combination thereof; an aryl, a heteroaryl, a substituted aryl, a substituted heteroarylaryl, an aryl halide, a substituted aryl halide, a benzyl or substituted benzyl, a biphenyl or substituted biphenyl, an aryloxy, an arylthio, an arylamine, or any substituted form thereof; -R 2 OH, -R 2 C(O)OH, -R 2 C(O)OR 2 , -R 2 OR 2 , -R 2 S.R. 2 , -R 2 CHO, -R 2 X (wherein X is a halogen atom), -R 2 C(O)NH2, -R 2 C(O)NR 2 , -R 2 NH3 + , -R 2 NH2, -R 2 NO2, -R 2 NHR 2 , -R 2 NR 2 R 2 , -R 2 N3, -R 2 OPO(OH)2, -R 2 OSO(OH)2, or any derivative or combination thereof, and each R 2 are independently any identical or different linear, branched or cyclic C1-C 20 Alkyl, C1-C 20 Alkenyl, C1-C 20 Alkynyl, C1-C 20 Heteroalkyl, C1-C 20 Heteroalkenyl, C1-C 20 Heteroalkynyl, C1-C 20 Haloalkyl groups, C1-C 20 Haloalkenyl groups, C1-C 20 Haloalkynyl groups, C1-C 20 Halogenated heteroalkyl groups, C1-C 20 Halogenated heteroalkenyl groups, C1-C 20halogenated heteroalkynyl groups, or any substituted or combined form thereof, where n is an integer of at least 5-10.
[0021] In an eleventh aspect, a method of modifying the surface of graphene is provided. The method can include forming a self-assembled monolayer, the self-assembled monolayer being disposed on the outer surface of the graphene layer through non-covalent interactions between the self-assembled monolayer and the π-electron system of graphene. The self-assembled monolayer can include one or more of a pyrarene, a substituted pyrarene, a calixarene, a substituted calixarene, a peralkylated cyclodextrin, a substituted peralkylated cyclodextrin, a pyrene or a substituted pyrene, or a derivative thereof. The method can include quantifying the degree of surface coverage of the self-assembled monolayer using sessile drop contact angle measurements, Raman spectroscopy, or X-ray photoelectron spectroscopy.
[0022] In a twelfth aspect, in addition to one or more of the preceding or following aspects, or as an alternative to certain aspects, the method can further include selecting a derivatized graphene layer that exhibits a Langmuir theta value of at least 0.9.
[0023] In a thirteenth aspect, in addition to one or more of the preceding or following aspects, or as an alternative to some aspects, the method can further include selecting a derivatized graphene layer that exhibits a Langmuir theta value of at least 0.98.
[0024] In a fourteenth aspect, in addition to one or more of the preceding or following aspects, or as an alternative to some aspects, a self-assembled monolayer suitable for use in the methods herein has the formula: JPEG0007592070000007.jpg52170
[0025] and In the formula, each R 0is independently -R 1 , -OR 1 or -SR 1 Each R 1 are independently H; -OH; =O; any linear, branched or cyclic C1-C 20 Alkyl, C1-C 20 Alkenyl, C1-C 20 Alkynyl, C1-C 20 Heteroalkyl, C1-C 20 Heteroalkenyl, C1-C 20 Heteroalkynyl, C1-C 20 Haloalkyl groups, C1-C 20 Haloalkenyl groups, C1-C 20 Haloalkynyl groups, C1-C 20 Halogenated heteroalkyl groups, C1-C 20 Halogenated heteroalkenyl groups, C1-C 20 a halogenated heteroalkynyl group, or any combination thereof; an aryl, a heteroaryl, a substituted aryl, a substituted heteroarylaryl, an aryl halide, a substituted aryl halide, a benzyl or substituted benzyl, a biphenyl or substituted biphenyl, an aryloxy, an arylthio, an arylamine, or any substituted form thereof; -R 2 OH, -R 2 C(O)OH, -R 2 C(O)OR 2 , -R 2 OR 2 , -R 2 S.R. 2 , -R 2 CHO, -R 2 X (wherein X is a halogen atom), -R 2 C(O)NH 2 , -R 2 C(O)NR 2 , -R 2 NH 3+ , -R 2 NH 2 , -R 2 NO 2 , -R 2 NHR 2 , -R 2 NR 2 R 2, -R 2 N 3 , -R 2 OPO(OH) 2 , -R 2 OSO(OH) 2 or any derivative or combination thereof, each R 2 are independently any identical or different linear, branched or cyclic C1-C 20 Alkyl, C1-C 20 Alkenyl, C1-C 20 Alkynyl, C1-C 20 Heteroalkyl, C1-C 20 Heteroalkenyl, C1-C 20 Heteroalkynyl, C1-C 20 Haloalkyl groups, C1-C 20 Haloalkenyl groups, C1-C 20 Haloalkynyl groups, C1-C 20 Halogenated heteroalkyl groups, C1-C 20 Halogenated heteroalkenyl groups, C1-C 20 halogenated heteroalkynyl groups, or any substituted or combined form thereof, where n is an integer of at least 5-15.
[0026] In a fifteenth embodiment, in addition to one or more of the preceding or following embodiments, or as an alternative to certain embodiments, the self-assembled monolayer has the formula: JPEG0007592070000008.jpg49170
[0027] The substituted pillarenes include In the formula, each R 0 is independently -R 1 , -OR 1 or -SR 1 Each R 1 are independently H; -OH; any linear, branched or cyclic C1-C 20 Alkyl, C1-C 20 Alkenyl, C1-C 20 Alkynyl, C1-C 20 Heteroalkyl, C1-C 20Heteroalkenyl, C1-C 20 Heteroalkynyl, C1-C 20 Haloalkyl groups, C1-C 20 Haloalkenyl groups, C1-C 20 Haloalkynyl groups, C1-C 20 Halogenated heteroalkyl groups, C1-C 20 Halogenated heteroalkenyl groups, C1-C 20 a halogenated heteroalkynyl group, or any combination thereof; an aryl, a heteroaryl, a substituted aryl, a substituted heteroarylaryl, an aryl halide, a substituted aryl halide, a benzyl or substituted benzyl, a biphenyl or substituted biphenyl, an aryloxy, an arylthio, an arylamine, or any substituted form thereof; -R 2 OH, -R 2 C(O)OH, -R 2 C(O)OR 2 , -R 2 OR 2 , -R 2 S.R. 2 , -R 2 CHO, -R 2 X (wherein X is a halogen atom), -R 2 C(O)NH2, -R 2 C(O)NR 2 , -R 2 NH3 + , -R 2 NH2, -R 2 NO2, -R 2 NHR 2 , -R 2 NR 2 R 2 , -R 2 N3, -R 2 OPO(OH)2, -R 2 OSO(OH)2, or any derivative or combination thereof, and each R 2 are independently any identical or different linear, branched or cyclic C1-C 20 Alkyl, C1-C 20 Alkenyl, C1-C 20 Alkynyl, C1-C 20 Heteroalkyl, C1-C 20Heteroalkenyl, C1-C 20 Heteroalkynyl, C1-C 20 Haloalkyl groups, C1-C 20 Haloalkenyl groups, C1-C 20 Haloalkynyl groups, C1-C 20 Halogenated heteroalkyl groups, C1-C 20 Halogenated heteroalkenyl groups, C1-C 20 halogenated heteroalkynyl groups, or any substituted or combined form thereof, where x is an integer of at least 0-15, y is an integer of at least 0-15, and n is an integer of at least 5-15.
[0028] In a sixteenth aspect, in addition to one or more of the preceding or following aspects, or as an alternative to some aspects, the self-assembled monolayer comprises: JPEG0007592070000009.jpg60170
[0029] JPEG0007592070000010.jpg63170
[0030] or JPEG0007592070000011.jpg62170
[0031] and wherein the calixarene may have any of the following formulas: In the formula, each R 0 are independent of each other, -R 1 , -OR 1 or -SR 1 Each R 1 are independently H; -OH; any linear, branched or cyclic C1-C 20 Alkyl, C1-C 20 Alkenyl, C1-C 20 Alkynyl, C1-C 20 Heteroalkyl, C1-C 20 Heteroalkenyl, C1-C 20 Heteroalkynyl, C1-C 20 Haloalkyl groups, C1-C 20Haloalkenyl groups, C1-C 20 Haloalkynyl groups, C1-C 20 Halogenated heteroalkyl groups, C1-C 20 Halogenated heteroalkenyl groups, C1-C 20 a halogenated heteroalkynyl group, or any combination thereof; an aryl, a heteroaryl, a substituted aryl, a substituted heteroarylaryl, an aryl halide, a substituted aryl halide, a benzyl or substituted benzyl, a biphenyl or substituted biphenyl, an aryloxy, an arylthio, an arylamine, or any substituted form thereof; -R 2 OH, -R 2 C(O)OH, -R 2 C(O)OR 2 , -R 2 OR 2 , -R 2 S.R. 2 , -R 2 CHO, -R 2 X (wherein X is a halogen atom), -R 2 C(O)NH2, -R 2 C(O)NR 2 , -R 2 NH3 + , -R 2 NH2, -R 2 NO2, -R 2 NHR 2 , -R 2 NR 2 R 2 , -R 2 N3, -R 2 OPO(OH)2, -R 2 OSO(OH)2, or any derivative or combination thereof, and each R 2 are independently any identical or different linear, branched or cyclic C1-C 20 Alkyl, C1-C 20 Alkenyl, C1-C 20 Alkynyl, C1-C 20 Heteroalkyl, C1-C 20 Heteroalkenyl, C1-C 20 Heteroalkynyl, C1-C 20 Haloalkyl groups, C1-C 20Haloalkenyl groups, C1-C 20 Haloalkynyl groups, C1-C 20 Halogenated heteroalkyl groups, C1-C 20 Halogenated heteroalkenyl groups, C1-C 20 halogenated heteroalkynyl groups, or any substituted or combined form thereof, where n is an integer of at least 3-15.
[0032] In a seventeenth aspect, in addition to one or more of the preceding or following aspects, or as an alternative to some aspects, the self-assembled monolayer comprises: JPEG0007592070000012.jpg44170
[0033] and substituted peralkylated cyclodextrins which may have the formula: In the formula, each R 0 is independently -R 1 , -OR 1 or -SR 1 Each R 1 are independently H; any linear, branched or cyclic C1-C 20 Alkyl, C1-C 20 Alkenyl, C1-C 20 Alkynyl, C1-C 20 Heteroalkyl, C1-C 20 Heteroalkenyl, C1-C 20 Heteroalkynyl, C1-C 20 Haloalkyl groups, C1-C 20 Haloalkenyl groups, C1-C 20 Haloalkynyl groups, C1-C 20 Halogenated heteroalkyl groups, C1-C 20 Halogenated heteroalkenyl groups, C1-C 20 a halogenated heteroalkynyl group, or any combination thereof; an aryl, a heteroaryl, a substituted aryl, a substituted heteroarylaryl, an aryl halide, a substituted aryl halide, a benzyl or substituted benzyl, a biphenyl or substituted biphenyl, an aryloxy, an arylthio, an arylamine, or any substituted form thereof; -R 2OH, -R 2 C(O)OH, -R 2 C(O)OR 2 , -R 2 OR 2 , -R 2 S.R. 2 , -R 2 CHO, -R 2 X (wherein X is a halogen atom), -R 2 C(O)NH2, -R 2 C(O)NR 2 , -R 2 NH3 + , -R 2 NH2, -R 2 NO2, -R 2 NHR 2 , -R 2 NR 2 R 2 , -R 2 N3, -R 2 OPO(OH)2, -R 2 OSO(OH)2, or any derivative or combination thereof, and each R 2 are independently any identical or different linear, branched or cyclic C1-C 20 Alkyl, C1-C 20 Alkenyl, C1-C 20 Alkynyl, C1-C 20 Heteroalkyl, C1-C 20 Heteroalkenyl, C1-C 20 Heteroalkynyl, C1-C 20 Haloalkyl groups, C1-C 20 Haloalkenyl groups, C1-C 20 Haloalkynyl groups, C1-C 20 Halogenated heteroalkyl groups, C1-C 20 Halogenated heteroalkenyl groups, C1-C 20 halogenated heteroalkynyl groups, or any substituted or combined form thereof, where n is an integer of at least 5-10.
[0034] In an eighteenth aspect, a method of detecting an analyte is included. The method can include obtaining a gaseous sample from a patient and contacting the gaseous sample with one or more graphene varactors. Each of the one or more graphene varactors can comprise a graphene layer and a self-assembled monolayer, the self-assembled monolayer disposed on an outer surface of the graphene layer through non-covalent interactions between the self-assembled monolayer and the pi-electron system of graphene. The self-assembled monolayer can include at least one selected from the group consisting of pyrarene, substituted pyrarene, calixarene, substituted calixarene, peralkylated cyclodextrin, substituted peralkylated cyclodextrin, pyrenes or substituted pyrenes, or derivatives thereof.
[0035] In a nineteenth aspect, in addition to one or more of the preceding or following aspects, or as an alternative to some aspects, the method may further include measuring a differential response in the electrical properties of the one or more graphene varactors due to binding of one or more analytes present in the gaseous sample.
[0036] In a twentieth aspect, in addition to one or more of the preceding or following aspects, or as an alternative to some aspects, the electrical property may be selected from the group consisting of capacitance or resistance.
[0037] This Summary is an overview of some of the teachings of the present application and is not intended to be an exclusive or exhaustive treatment of the present subject matter. Further details are found in the detailed description and the appended claims. Other aspects will become apparent to those skilled in the art upon reading and understanding the following detailed description and viewing the drawings that form a part thereof. Each of said detailed description and drawings should not be construed in a limiting sense. The scope of the present application is defined by the appended claims and their legal equivalents.
[0038] The aspects may be more fully understood in connection with the following figures. [Brief description of the drawings]
[0039] [Figure 1] 1 is a schematic perspective view of a graphene varactor according to various embodiments herein; [Diagram 2] 1 is a schematic cross-sectional view of a portion of a graphene varactor according to various embodiments herein. [Diagram 3] 1 is a schematic plan view of a chemical sensor element according to various embodiments herein; [Figure 4] 1 is a schematic diagram of a portion of a measurement zone according to various embodiments herein. [Diagram 5] 2 is a circuit diagram of a portion of a passive sensor circuit and a readout circuit according to various embodiments herein. [Figure 6] 1 is a schematic diagram of a system for sensing a gaseous analyte according to various embodiments herein. [Figure 7] 1 is a schematic diagram of a system for sensing a gaseous analyte according to various embodiments herein. [Figure 8] 1 is a schematic cross-sectional view of a portion of a chemical sensor element according to various embodiments herein. [Figure 9] 1 is an exemplary plot of relative surface coverage as a function of concentration according to various embodiments herein. [Figure 10] 11 is a representative plot of relative surface coverage as a function of the logarithm of the concentration presented in FIG. 10, according to various embodiments herein. [Figure 11] 1 is an exemplary plot of relative surface coverage as a function of concentration according to various embodiments herein. [Figure 12] 12 is a representative plot of relative surface coverage as a function of the logarithm of the concentration presented in FIG. 11, in accordance with various embodiments herein. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0040] While the embodiments are susceptible to various modifications and alternative forms, details thereof have been shown by way of example and drawings and will be described in detail. It should be understood, however, that the scope of the specification is not limited to the specific aspects described. Rather, the intention is to cover modifications, equivalents, and alternatives that are within the spirit and scope of the specification.
[0041] Embodiments herein relate to chemical sensors, medical devices and systems including chemical sensors, and related methods for detecting compounds in gaseous samples, such as, but not limited to, a patient's breath. In some embodiments, the chemical sensors herein may be based on non-covalent surface modification of graphene with various surface receptors, including pyrarene, substituted pyrarene, calixarenes, substituted calixarenes, peralkylated cyclodextrins, substituted peralkylated cyclodextrins, pyrenes, or substituted pyrenes. As used herein, the term "pillarene" may be used interchangeably with the term "pillarene".
[0042] Graphene is a form of carbon that contains a single layer of carbon atoms in a hexagonal lattice. Graphene is made up of closely packed sp 2 It has great strength and stability due to hybrid orbitals, with each carbon atom forming one sigma (σ) bond with each of its three neighboring carbon atoms and one p orbital protruding from the plane of the hexagon. The p orbitals of the hexagonal lattice can hybridize to form π bands on the surface of graphene suitable for non-covalent electrostatic interactions, including π-π stacking interactions with other molecules.
[0043] Pillarenes are a group of heterocyclic macrocycles containing 5 to 15 modified hydroquinone subunits, each connected by a methylene (-CH2-) bridge. The basic core structure of a pillarene is: JPEG0007592070000013.jpg53170
[0044] The hydroquinone subunits of pyrarene form a symmetric pillar-like structure that defines a central cavity that can capture analytes of interest for chemical sensing, making pillarenes a new class of macrocycles for host-guest chemistry.
[0045] Calixarenes are a group of heterocyclic macrocycles with 3 to 15 aromatic moieties derived from compounds such as phenols, each connected by a substituted or unsubstituted methylene (-CH2-) bridge. One exemplary structure of a calixarene is shown below: JPEG0007592070000014.jpg54170
[0046] Calixarenes are a new class of macrocycles for host-guest chemistry because the subunits of the calixarene can form a cup-like shape that defines a central cavity that can trap analytes of interest for chemical sensing.
[0047] Cyclodextrins are a group of cyclic oligosaccharides with 5 to 10 glucose subunits linked by 1,4 glycosidic bonds, which include α-peralkylated cyclodextrin, β-peralkylated cyclodextrin, and γ-peralkylated cyclodextrin, and their derivatives. The basic core structure of peralkylated cyclodextrin is shown below: JPEG0007592070000015.jpg43170
[0048] The glucose subunits of cyclodextrin can form a toroidal structure with one large opening and one small opening exposed to the environment. The internal cavity defined by the toroidal structure of cyclodextrin allows it to form complexes with other molecules for host-guest chemistry.
[0049] Without wishing to be bound by any particular theory, host-guest chemistry is believed to describe one or more complexes that can be formed by two or more molecules that are held together by intermolecular forces other than covalent bonds. Pillarenes, calixarenes, and cyclodextrins can be functionalized on graphene through non-covalent π-π stacking interactions or non-covalent -CH-π stacking interactions due to electron-rich aromatic rings and one or more alkyloxy groups attached to the aromatic rings.
[0050] Without wishing to be bound by any particular theory, it is believed that hydrogen atoms in the hydrocarbon groups (e.g., alkyl chains) can interact with the π-electron system on the surface of graphene through electrostatic interactions. Hydrogen atoms are less electronegative, and therefore these hydrogen atoms carry a partial positive charge. The partial positive charges on the hydrogen atoms of the alkyl chains can participate in electrostatic interactions with the π-electron system of the π-bands at the surface of graphene. The alkyl chains can be adsorbed on the graphene surface in an all-trans configuration along the carbon-carbon backbone, such that the carbon atoms lie in one plane that is either perpendicular or parallel to the graphene surface.
[0051] As an example, the trans conformation of an alkyl chain with a vertical orientation of its carbon-carbon backbone along the surface of graphene results in a configuration in which every other -CH2- group of the alkyl chain has its hydrogen atom pointing towards the graphene. Therefore, the alkyl chain can orient itself with respect to the graphene surface such that the -CH2- hydrogens of every other -CH2- group are positioned at the same distance from the graphene surface, maximizing hydrogen-graphene interactions. Thus, the alkyl chain can interact with the graphene surface along the length of the alkyl chain. It is also believed that hydrogen atoms of alkenyl and alkynyl chains and their derivatives can interact with the graphene surface as well.
[0052] Non-covalent functionalization of graphene with self-assembled monolayers of receptor molecules, including, for example, hydrocarbon-substituted pillarenes, calixarenes, or peralkylated cyclodextrins, does not significantly affect the atomic structure of graphene and provides stable graphene-based sensors with high sensitivity at parts per billion (ppb) or parts per million (ppm) levels for a number of volatile organic compounds (VOCs). Thus, embodiments herein can be used to detect VOCs and / or their unique binding patterns, which in turn can be utilized to identify disease states.
[0053] 1, there is shown a schematic diagram of a graphene-based variable capacitor (i.e., graphene varactor) 100 according to embodiments herein. It will be understood that graphene varactors can be fabricated in a variety of geometric shapes by a variety of methods, and the graphene varactor shown in FIG. 1 is only one example according to embodiments herein.
[0054] The graphene varactor 100 can include an insulator layer 102, a gate electrode 104 (or "gate contact"), a dielectric layer (not shown in FIG. 1), one or more graphene layers, such as graphene layers 108a, 108b, and a contact electrode 110 (or "graphene contact"). In some embodiments, the graphene layers 108a-108b can be continuous, while in other embodiments, the graphene layers 108a-108b can be discontinuous. The gate electrode 104 can be deposited in one or more recesses formed in the insulator layer 102. The insulator layer 102 can be formed from an insulating material, such as silicon dioxide, formed on a silicon substrate (wafer), or the like. The gate electrode 104 can be formed from a conductive material, such as chromium, copper, gold, silver, nickel, tungsten, aluminum, titanium, palladium, platinum, iridium, and any combination or alloy thereof, which can be deposited on top of the insulator layer 102 or buried within the insulator layer 102. A dielectric layer may be disposed on a surface of the insulator layer 102 and over the gate electrode 104. The graphene layers 108a-108b may be disposed on the dielectric layer, which is described in more detail below with reference to FIG.
[0055] The graphene varactor 100 includes eight gate electrode fingers 106a-106h. Although the graphene varactor 100 is shown with eight gate electrode fingers 106a-106h, it will be understood that any number of gate electrode finger configurations may be envisioned. In some embodiments, an individual graphene varactor may include fewer than eight gate electrode fingers. In some embodiments, an individual graphene varactor may include more than eight gate electrode fingers. In other embodiments, an individual graphene varactor may include two gate electrode fingers. In some embodiments, an individual graphene varactor may include one, two, three, four, five, six, seven, eight, nine, ten, or more gate electrode fingers.
[0056] The graphene varactor 100 may include one or more contact electrodes 110 disposed on portions of the graphene layers 108a, 108b. The contact electrodes 110 may be formed from a conductive material such as chromium, copper, gold, silver, nickel, tungsten, aluminum, titanium, palladium, platinum, iridium, and any combination or alloy thereof. Further aspects of exemplary graphene varactors may be found in U.S. Pat. No. 9,513,244, the contents of which are incorporated herein by reference in their entirety.
[0057] The graphene varactors described herein can include those in which a single graphene layer is surface-modified through non-covalent interactions between the graphene and a molecule substituted with a hydrocarbon group. In some embodiments, the surface of the single graphene layer can be surface-modified through non-covalent electrostatic interactions between the graphene and any one of a number of pillarenes, substituted pillarenes, or derivatives thereof. In some embodiments, the surface of the single graphene layer can be surface-modified through non-covalent electrostatic interactions between the graphene and any one of a number of calixarenes, substituted calixarenes, or derivatives thereof. In some embodiments, the surface of the single graphene layer can be surface-modified through non-covalent electrostatic interactions between the graphene and any one of a number of peralkylated cyclodextrins or substituted peralkylated cyclodextrins, or derivatives thereof. In other embodiments, the surface of a single graphene layer may be surface modified through non-covalent π-π stacking interactions between the graphene and any one of a number of pyrarene, substituted pyrarene, calixarenes, substituted calixarenes, peralkylated cyclodextrin, substituted peralkylated cyclodextrin, pyrenes or substituted pyrenes, or derivatives thereof. Details regarding graphene varactors, pyrarene, substituted pyrarene, calixarenes, substituted calixarenes, peralkylated cyclodextrin, substituted peralkylated cyclodextrin, pyrenes or substituted pyrenes suitable for use herein are described more fully below.
[0058] It will be appreciated that in various embodiments herein, graphene can be replaced with other similar monolayer structural materials, including, for example, borophene or other structural analogs of graphene. Borophene is a monolayer of boron atoms arranged in various crystalline forms.
[0059] Referring now to Figure 2, a schematic cross-sectional view of a portion of a graphene varactor according to various embodiments herein is shown. The graphene varactor 200 can include an insulator layer 102 and a gate electrode 104 embedded in the insulator layer 102. The gate electrode 104 can be formed by depositing a conductive material in a recess in the insulator layer 102 as described above with reference to Figure 1. A dielectric layer 202 can be formed on a surface of the insulator layer 102 and over the gate electrode 104. In some examples, the dielectric layer 202 can be formed from a material such as silicon dioxide, aluminum oxide, hafnium dioxide, zirconium dioxide, hafnium silicate, or zirconium silicate.
[0060] The graphene varactor 200 may include a single graphene layer 204 that may be disposed on the surface of the dielectric layer 202. The graphene layer 204 may be surface modified with a self-assembled monolayer 206. The self-assembled monolayer 206 may be formed from a homogenous population of pillarenes, substituted pyrarenes, or derivatives thereof that are disposed on the outer surface of the graphene layer 204 through non-covalent interactions. In some embodiments, the self-assembled monolayer 206 may be formed from a homogenous population of calixarenes, substituted calixarenes, or derivatives thereof. In other embodiments, the self-assembled monolayer 206 may be formed from a homogenous population of peralkylated cyclodextrins, substituted peralkylated cyclodextrins, or derivatives thereof. Exemplary pillarenes, substituted pyrarenes, calixarenes, substituted calixarenes, peralkylated cyclodextrins, substituted peralkylated cyclodextrins, pyrenes or substituted pyrenes, or derivatives of any of the foregoing are described more fully below. The self-assembled monolayer 206 can provide at least 90% surface coverage (by area) of the graphene layer 204. In some embodiments, the self-assembled monolayer 206 can provide at least 95% surface coverage of the graphene layer 204. In other embodiments, the self-assembled monolayer 206 can provide at least 98% surface coverage of the graphene layer 204.
[0061] In some embodiments, the self-assembled monolayer can provide a surface coverage (by area) of at least 50%, 60%, 70%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% of the graphene layer. It will be understood that the self-assembled monolayer can provide a surface coverage that is within a range, and any of the foregoing percentages can be the lower or upper limit of that range, provided that the lower limit of the range is less than the upper limit of that range.
[0062] It will be appreciated that in some embodiments, the self-assembly of the pyrarene, substituted pyrarene, calixarenes, substituted calixarenes, peralkylated cyclodextrins, substituted peralkylated cyclodextrins, pyrenes or substituted pyrenes, or derivatives thereof on the surface of the graphene layer may include self-assembly into multiple layers, such as multilayers. Multilayers can be detected and quantified by techniques such as scanning tunneling microscopy (STM) and other scanning probe microscopy. References herein to percentages of coverage greater than 100% are intended to refer to situations where a portion of the surface area is covered by multiple layers, for example, two, three, or potentially more layers of the compound used. Thus, references herein to a coverage of 105% are intended to indicate that about 5% of the surface area includes coverage of multiple layers on the graphene layer. In some embodiments, the graphene surface can include a surface coverage of 101%, 102%, 103%, 104%, 105%, 110%, 120%, 130%, 140%, 150%, or 175% of the graphene layers. It will be understood that the multilayer surface coverage of the graphene layers can be within a range of surface coverage, and any of the foregoing percentages can be the lower or upper limit of the range, provided that the lower limit of the range is less than the upper limit of the range. For example, the range of coverage can include, but is not limited to, 50% to 150% by surface area, 80% to 120% by surface area, 90% to 110% by surface area, or 99% to 120% by surface area.
[0063] In some embodiments, self-assembled monolayers suitable for use herein can provide coverage of the graphene surface with a monolayer as quantified by at least some minimum threshold Langmuir theta value, but can avoid covering a majority of the graphene surface with a multilayer thicker than a monolayer. Details regarding the Langmuir theta values of specific self-assembled monolayers and their identification using Langmuir adsorption theory are described more fully below. In some embodiments, self-assembled monolayers suitable for use herein provide a Langmuir theta value of at least 0.95. In some embodiments, self-assembled monolayers suitable for use herein provide a Langmuir theta value of at least 0.98. In some embodiments, the self-assembled monolayer can provide a Langmuir theta value of at least 0.85, 0.86, 0.87, 0.88, 0.89, 0.90, 0.91, 0.92, 0.93, 0.94, 0.95, 0.96, 0.97, 0.98, 0.99, or 1.0. It will be understood that the self-assembled monolayer can provide a range of Langmuir theta values, and any of the aforementioned Langmuir theta values can be the lower or upper limit of the range, provided that the lower limit of the range is less than the upper limit of the range.
[0064] Referring now to FIG. 3, a schematic plan view of a chemical sensor element 300 according to various embodiments herein is shown. The chemical sensor element 300 can include a substrate 302. It will be appreciated that the substrate can be formed from many different materials. By way of example, the substrate can be formed from silicon, glass, quartz, sapphire, polymers, metals, glasses, ceramics, cellulosic materials, composites, metal oxides, and the like. The thickness of the substrate can vary. In some embodiments, the substrate has sufficient structural integrity to be handled without excessive flexing that may damage components on the substrate. In some embodiments, the substrate has a thickness of about 0.05 mm to about 5 mm. The length and width of the substrate can also vary. In some embodiments, the length (or major axis) can be about 0.2 cm to about 10 cm. In some embodiments, the length (or major axis) can be about 20 μm to about 1 cm. In some embodiments, the width (perpendicular to the major axis) can be about 0.2 cm to about 8 cm. In some embodiments, the width (perpendicular to the major axis) can be about 20 μm to about 0.8 cm. In some embodiments, the graphene-based chemical sensor may be disposable.
[0065] A first measurement zone 304 may be disposed on the substrate 302. In some embodiments, the first measurement zone 304 may define a portion of a first gas flow path. The first measurement zone (or gas sample zone) 304 may include a plurality of individual graphene-based variable capacitors (i.e., graphene varactors) capable of sensing an analyte in a gaseous sample, such as a breath sample. A second measurement zone (or environmental sample zone) 306 separate from the first measurement zone 304 may also be disposed on the substrate 302. The second measurement zone 306 may also include a plurality of individual graphene varactors. In some embodiments, the second measurement zone 306 may include the same (type and / or number) of individual graphene varactors as in the first measurement zone 304. In some embodiments, the second measurement zone 306 may include only a portion of the individual graphene varactors in the first measurement zone 304. In operation, data collected from the first measurement zone, which may reflect the gaseous sample being analyzed, may be corrected or normalized based on data collected from the second measurement zone, which may reflect an analyte present in the environment.
[0066] In some embodiments, a third measurement zone (drift control or witness zone) 308 may also be disposed on the substrate. The third measurement zone 308 may include a plurality of individual graphene varactors. In some embodiments, the third measurement zone 308 may include the same (type and / or number) of individual graphene varactors as are in the first measurement zone 304. In some embodiments, the third measurement zone 308 may include only a portion of the individual graphene varactors that are in the first measurement zone 304. In some embodiments, the third measurement zone 308 may include individual graphene varactors that are different from those in the first measurement zone 304 and the second measurement zone 306. Aspects of the third measurement zone are described in more detail below.
[0067] The first, second and third measurement zones may be of the same size or of different sizes. The chemical sensor element 300 may also include a component 310 for storing reference data. The component 310 for storing reference data may be an electronic data storage device, an optical data storage device, a printed data storage device (e.g. a printed code), etc. The reference data may include, but is not limited to, data regarding the third measurement zone (described in more detail below).
[0068] In some embodiments, chemical sensor elements embodied herein can include electrical contacts (not shown) that can be used to provide power to components on the chemical sensor element 300 and / or can be used to read data related to the measurement zone and / or data from that stored in the components 310. However, in other embodiments, no external electrical contacts are present on the chemical sensor element 300.
[0069] It will be appreciated that many different circuit designs can be used to collect data and / or signals from the chemical sensor elements herein, including both direct contact circuit designs and passive wireless sensing circuit designs. Some exemplary measurement circuits are described in U.S. Patent Application Publication No. 2019 / 0025237, the contents of which are incorporated herein by reference.
[0070] It will be appreciated that chemical sensor elements embodied herein may include those adapted for passive wireless sensing. A schematic diagram of a portion of a passive sensor circuit 502 and a readout circuit 522 is shown in FIG. 5 and described in more detail below. In a passive wireless sensing configuration, a graphene varactor may be integrated with an inductor such that one terminal of the graphene varactor contacts one end of the inductor and a second terminal of the graphene varactor contacts a second terminal of the inductor. In some embodiments, the inductor may be located on the same substrate as the graphene varactor, while in other embodiments, the inductor may be located in an off-chip location.
[0071] 4, a schematic diagram of a portion of a measurement zone 400 is shown in accordance with various embodiments herein. A plurality of individual graphene varactors 402 may be arranged in an array in the measurement zone 400. In some embodiments, the chemical sensor element may include a plurality of graphene varactors arranged in an array within the measurement zone. In some embodiments, the plurality of graphene varactors may be identical, while in other embodiments, the plurality of graphene varactors may be different from one another.
[0072] In some embodiments, the individual graphene varactors may be heterogeneous in that they all differ from one another in terms of the specificity of their binding behavior for a particular analyte. In some embodiments, some individual graphene varactors may be duplicated for validation purposes, but are otherwise heterogeneous from other individual graphene varactors. Additionally, in other embodiments, the individual graphene varactors may be homogeneous. Although the individual graphene varactors 402 in FIG. 4 are shown as squares organized in a lattice, it will be understood that the individual graphene varactors can take many different shapes (including, but not limited to, various polygons, circles, ellipses, irregular shapes, etc.), and similarly, groups of individual graphene varactors can be arranged in many different patterns (including, but not limited to, star patterns, zigzag patterns, radial patterns, symbolic patterns, etc.).
[0073] In some embodiments, the order of the particular individual graphene varactors 402 across the length 412 and width 414 of the measurement zone may be substantially random. In other embodiments, the order may be specific. For example, in some embodiments, the measurement zone may be ordered such that particular individual graphene varactors 402 for lower molecular weight analytes are located further from the incoming gas stream compared to particular individual graphene varactors 402 for higher molecular weight analytes located closer to the incoming gas stream. Thus, chromatographic effects that may serve to separate compounds of different molecular weights may be utilized to provide optimal binding of the compounds to their corresponding individual graphene varactors.
[0074] The number of individual graphene varactors in a particular measurement zone can be from about 1 to about 100,000. In some embodiments, the number of individual graphene varactors can be from about 1 to about 10,000. In some embodiments, the number of individual graphene varactors can be from about 1 to about 1,000. In some embodiments, the number of individual graphene varactors can be from about 2 to about 500. In some embodiments, the number of individual graphene varactors can be from about 10 to about 500. In some embodiments, the number of individual graphene varactors can be from about 50 to about 500. In some embodiments, the number of individual graphene varactors can be from about 1 to about 250. In some embodiments, the number of individual graphene varactors can be from about 1 to about 50.
[0075] Each of the individual graphene varactors suitable for use herein may include at least a portion of one or more electrical circuits. By way of example, in some embodiments, each of the individual graphene varactors may include one or more passive electrical circuits. In some embodiments, the graphene varactors may be provided such that they are directly integrated onto an electronic circuit. In some embodiments, the graphene varactors may be provided such that they are wafer bonded to a circuit. In some embodiments, the graphene varactors may include integrated readout electronics, such as a readout integrated circuit (ROIC). An electrical characteristic of the electrical circuit, including resistance or capacitance, may change upon binding, such as specific and / or non-specific binding, with a component from the gas sample.
[0076] Referring now to FIG. 5, a schematic diagram of a passive sensor circuit 502 and a portion of a readout circuit 552 according to various aspects of the present specification is shown. In some embodiments, the passive sensor circuit 502 can include a metal-oxide-graphene varactor 504 (where RS represents series resistance and CG represents varactor capacitor) connected to an inductor 510. The graphene varactor can be fabricated in various geometric shapes by various methods. As an example, in some embodiments, a gate electrode can be embedded in an insulator layer, as shown in FIG. 1 as gate electrode 104. The gate electrode can be formed by etching a recess in the insulator layer and then depositing a conductive material in the recess to form the gate electrode. A dielectric layer can be formed on a surface of the insulator layer and on the gate electrode. In some examples, the dielectric layer can be formed from a metal oxide, such as aluminum oxide, hafnium dioxide, zirconium dioxide, silicon dioxide, or another material, such as hafnium silicate or zirconium silicate. A surface-modified graphene layer can be disposed on the dielectric layer. A contact electrode can also be disposed on the surface of the surface-modified graphene layer, and is also shown in FIG.
[0077] Further aspects of exemplary graphene varactor structures can be found in US Pat. No. 9,513,244, the contents of which are incorporated herein by reference in their entirety. In various embodiments, a functionalized graphene layer (e.g., functionalized to include a receptor that binds an analyte) that is part of a graphene varactor and thus part of a sensor circuit, such as a passive sensor circuit, is exposed to a gas sample flowing over a surface of a measurement zone. The passive sensor circuits 502 can also include an inductor 510. In some embodiments, each passive sensor circuit 502 includes only a single varactor. In other embodiments, each passive sensor circuit 502 includes multiple varactors, e.g., in parallel.
[0078] In the passive sensor circuit 502, the capacitance of the electrical circuit changes upon binding of the graphene varactor with an analyte in the gas sample. The passive sensor circuit 502 can function as an LRC resonator circuit, whose resonant frequency changes upon binding of a component from the gas sample.
[0079] The read circuit 522 can be used to detect electrical characteristics of the passive sensor circuit 502. As an example, the read circuit 522 can be used to detect the resonant frequency and / or changes in the resonant frequency of the LRC resonator circuit. In some embodiments, the read circuit 522 can include a read coil having a resistance 524 and an inductance 526. When the sensor-side LRC circuit is at its resonant frequency, a plot of the phase of the impedance of the read circuit against frequency has a minimum (i.e., phase dip frequency). Sensing can occur when the capacitance of the varactor changes in response to binding of the analyte, which changes the value of the resonant frequency and / or phase dip frequency.
[0080] Referring now to FIG. 6, a schematic diagram of a system for sensing a gaseous analyte according to various embodiments herein is shown. The system 600 can include a housing 618. The system 600 can include a mouthpiece 602 into which the assessment subject can blow a breath sample. The gaseous breath sample can pass through an inlet conduit 604 and through an assessment sample (patient sample) injection port 606. The system 600 can also include a control sample (environment) injection port 608. The system 600 can also include a sensor element chamber 610 into which a disposable sensor element can be placed. The system 600 can also include a display screen 614 and a user input device 616, such as a keyboard. The system can also include a gas outlet port 612. The system 600 can also include a flow sensor in fluid communication with a gas flow associated with one or more of the assessment sample injection port 606 and the control sample injection port 608. It will be appreciated that many different types of flow sensors can be used. In some embodiments, a hot wire anemometer can be used to measure the air flow. In some embodiments, the system can include a CO 2 sensor in fluid communication with a gas stream associated with one or more of the evaluation sample injection port 606 and the control sample injection port 608 .
[0081] In various embodiments, the system 600 may also include other functional components. By way of example, the system 600 may include a humidity control module 640 and / or a temperature control module 642. The humidity control module may be in fluid communication with the gas streams associated with one or more of the evaluation sample injection port 606 and the control sample injection port 608 to adjust the humidity of one or both of the gas flow streams to make the relative humidity of the two streams substantially the same to prevent adverse effects on the readings obtained by the system. The temperature control module may be in fluid communication with the gas streams associated with one or more of the evaluation sample injection port 606 and the control sample injection port 608 to adjust the temperature of one or both of the gas flow streams to make the temperature of the two streams substantially the same to prevent adverse effects on the readings obtained by the system. By way of example, the air flowing into the control sample injection port may be at or above 37 degrees Celsius to match or exceed the temperature of the air coming from the patient. The humidity and temperature control modules may be upstream from the injection port, within the injection port, or within the housing 618 of the system 600 downstream from the injection port. In some embodiments, the humidity control module 640 and the temperature control module 642 may be integrated.
[0082] In some embodiments (not shown), the control sample injection port 608 of the system 600 can also be connected to the mouthpiece 602. In some embodiments, the mouthpiece 602 can be equipped with a switching airflow valve such that when the patient is inhaling, air flows from the control sample injection port 608 to the mouthpiece, and the system is configured to allow ambient air to flow across the appropriate control measurement zone (such as the second measurement zone). Then, when the patient exhales, the switching airflow valve can be switched to allow the breath sample from the patient to flow from the mouthpiece 602 through the inlet conduit 604 into the evaluation sample injection port 606 and across the appropriate sample (patient sample) measurement zone (such as the first measurement zone) on the disposable sensor element.
[0083] In one embodiment, a method of fabricating a chemical sensor element is included. The method can include depositing one or more measurement zones on a substrate. The method can further include depositing a plurality of individual graphene varactors in the measurement zones on the substrate. The method can include modifying a surface of the graphene layer with a pyrarene, a substituted pyrarene, a calixarene, a substituted calixarene, a peralkylated cyclodextrin, a substituted peralkylated cyclodextrin, a pyrene or a substituted pyrene, or a derivative thereof to form a self-assembled monolayer on the outer surface of the graphene layer through non-covalent interactions, thereby generating one or more individual graphene varactors. The method can include quantifying the degree of surface coverage of the self-assembled monolayer using sessile drop contact angle measurements, Raman spectroscopy, or X-ray photoelectron spectroscopy. The method can include selecting a derivatized graphene layer exhibiting a Langmuir theta value of at least 0.9, as described more fully below. In some embodiments, the method can further include selecting a derivatized graphene layer exhibiting a Langmuir theta value of at least 0.98. The method may further comprise depositing a component on the substrate for storing the reference data. In some embodiments, the measurement zones may all be located on the same side of the substrate. In other embodiments, the measurement zones may be located on different sides of the substrate.
[0084] In one embodiment, a method of assaying one or more gas samples is included. The method can include inserting a chemical sensor element into a sensing device. The chemical sensor element can include a substrate and a first measurement zone comprising a plurality of individual graphene varactors. The first measurement zone can define a portion of a first gas flow path. The chemical sensor element can further include a second measurement zone separate from the first measurement zone. The second measurement zone can also include a plurality of individual graphene varactors. The second measurement zone can be disposed outside of the first gas flow path.
[0085] The method may further include encouraging the subject to blow air into the sensing device to follow the first gas flow path. In some embodiments, the CO2 content of the air from the subject is monitored and sampling with the disposable sensor element occurs during a plateau in CO2 content, since air originating from the patient's alveoli is believed to have the highest content of compounds for analysis, such as volatile organic compounds. In some embodiments, the method may include monitoring the total mass flow rate of the breath sample and the control (or environmental) air sample using a flow sensor. The method may further include obtaining information from the individual graphene varactors to identify the analyte binding state of the individual graphene varactors. The method may further include discarding the disposable sensor element upon completion of sampling.
[0086] 7, a schematic diagram of a system 700 for sensing a gaseous analyte according to various embodiments herein is shown. In this embodiment, the system is handheld. The system 700 may include a housing 718. The system 700 may include a mouthpiece 702 into which the subject may blow a breath sample. The system 700 may also include a display screen 714 and a user input device 716, such as a keyboard. The system may also include a gas exit port 712. The system may also include various other components, such as those described above with respect to FIG. 6.
[0087] In some embodiments, one of the measurement zones may be configured to indicate changes (or drift) in the chemical sensor element that may occur as a result of aging and exposure to varying conditions (e.g., heat exposure, light exposure, molecular oxygen exposure, humidity exposure, etc.) during storage and handling prior to use. In some embodiments, a third measurement zone may be configured for this purpose.
[0088] Referring now to FIG. 8, a schematic cross-sectional view of a portion of a chemical sensor element 800 according to various embodiments herein is shown. The chemical sensor element 800 can include a substrate 802 and an individual graphene varactor 804 disposed on the substrate 802 that is part of the measurement zone. Optionally, in some embodiments, the individual graphene varactor 804 can be encapsulated by an inert material 806, such as nitrogen gas or an inert liquid or solid. In this way, the individual graphene varactor 804 for the third measurement zone is shielded from contact with the gas sample and can therefore be used as a control or reference, particularly to control sensor drift that may occur between the time of manufacture and the time of use of the disposable sensor element. In some embodiments, such as when using an inert gas or liquid, the individual bonded detector can also include a barrier layer 808, which can be a layer of polymeric material, foil, or the like. In some cases, the barrier layer 808 can be removed immediately before use.
[0089] In one embodiment, a method of detecting one or more analytes is included. The method can include obtaining a gaseous sample from a patient. In some embodiments, the gaseous sample can include exhaled air. In other embodiments, the gaseous sample can include breath extracted from the patient's lungs through a catheter or other similar extraction device. In some embodiments, the extraction device can include an endoscope, bronchoscope, or tracheoscope. The method can also include contacting a graphene varactor with the gaseous sample, the graphene varactor comprising a graphene layer and a self-assembled monolayer disposed on an outer surface of the graphene layer through non-covalent interactions. In some embodiments, the self-assembled monolayer can provide a Langmuir Theta value of at least 0.9. In some embodiments, the method can further include selecting a derivatized graphene layer that exhibits a Langmuir Theta value of at least 0.98. Langmuir Theta values are described more fully below. In some embodiments, the method may include measuring a differential response in the capacitance of the graphene reactor due to binding of one or more analytes present in the gaseous sample, which in turn may be used to identify a disease state. In some embodiments, the method may include a self-assembled monolayer selected from at least one of pyrarene, substituted pyrarene, calixarene, substituted calixarene, peralkylated cyclodextrin, substituted peralkylated cyclodextrin, pyrenes or substituted pyrenes, or derivatives thereof.
[0090] Graphene Varactor The graphene varactors described herein can be used to sense one or more analytes in a gaseous sample, such as a patient's breath. The graphene varactors embodied herein can exhibit high sensitivity at or near parts per million (ppm) or parts per billion (ppb) levels to volatile organic compounds (VOCs) found in the gaseous sample. Adsorption of VOCs onto the surface of the graphene varactors can change the resistance, capacitance, or quantum capacitance of such devices and can be used to detect VOCs and / or patterns of binding by VOCs, which in turn can be utilized to identify disease states such as cancer, heart disease, infectious diseases, multiple sclerosis, Alzheimer's disease, Parkinson's disease, and the like. Graphene varactors can be used to detect individual analytes in gas mixtures as well as response patterns in highly complex mixtures. In some embodiments, one or more graphene varactors can be included to detect the same analyte in a gaseous sample. In some embodiments, one or more graphene varactors can be included to detect different analytes in a gaseous sample. In some embodiments, one or more graphene varactors may be included to detect multiple analytes in a gaseous sample.
[0091] An exemplary graphene varactor may comprise a graphene layer and a self-assembled monolayer disposed on an outer surface of the graphene layer, the self-assembled monolayer interacting with the graphene layer through non-covalent interactions as illustrated and described above with respect to FIG. 2. Self-assembled monolayers suitable for use herein may provide a Langmuir theta value of at least 0.9. Identification of the Langmuir theta value of a particular self-assembled monolayer using Langmuir adsorption theory is described more fully below. In some embodiments, self-assembled monolayers suitable for use herein provide a Langmuir theta value of at least 0.95. In some embodiments, self-assembled monolayers suitable for use herein provide a Langmuir theta value of at least 0.98.
[0092] The graphene varactors described herein can include a single graphene layer that is surface modified through non-covalent interactions with one or more receptor molecules including pyrarene, substituted pyrarene, calixarene, substituted calixarene, peralkylated cyclodextrin, substituted peralkylated cyclodextrin, pyrenes or substituted pyrenes, or derivatives thereof, as described elsewhere herein. The substituted pyrarene, substituted calixarene, substituted peralkylated cyclodextrin, or substituted pyrenes may be substituted with any number of functional groups as described herein, including, but not limited to, alkyl groups, alkenyl groups, alkynyl groups, heteroalkyl groups, heteroalkenyl groups, heteroalkynyl groups, haloalkyl groups, haloalkenyl groups, haloalkynyl groups, halogenated heteroalkyl groups, halogenated heteroalkenyl groups, halogenated heteroalkynyl groups, aryl groups, substituted aryl groups, heteroaryl groups, substituted heteroaryl groups, aryloxy groups, substituted aryloxy groups, arylthio groups, substituted arylthio groups, arylamine groups, substituted arylamine groups, halogenated aryl groups, substituted halogenated aryl groups, biphenyl groups, and / or substituted biphenyl groups.
[0093] As used herein, the term "alkyl" refers to any linear, branched, or cyclic hydrocarbon functional group containing in the range of 1 to 20 carbon atoms (i.e., C1-C 20 In some embodiments, an alkyl group herein refers to any linear, branched, or cyclic hydrocarbon functional group containing in the range of 6 to 18 carbon atoms (i.e., C6-C 18 In other embodiments, an alkyl group herein can include any linear, branched, or cyclic hydrocarbon functional group containing in the range of 10 to 16 carbon atoms (i.e., C 10 ~C 16 The alkyl groups described herein can have the general formula C, unless otherwise indicated. n H 2n+1 has.
[0094] As used herein, the term “alkenyl” refers to any linear, branched, or cyclic hydrocarbon functional group containing in the range of 1 to 20 carbon atoms, where an alkenyl group contains at least one carbon-carbon double bond (i.e., C1-C 20 In some embodiments, the alkenyl group herein can contain any linear, branched, or cyclic hydrocarbon functional group containing in the range of 6 to 18 carbon atoms, where the alkenyl group contains at least one carbon-carbon double bond (i.e., C6 to C8). 18 In other embodiments, the alkenyl groups herein can contain any linear, branched, or cyclic hydrocarbon functional group containing in the range of 10 to 16 carbon atoms, where the alkenyl group contains at least one carbon-carbon double bond (i.e., C 10 ~C 16 Alkenyl groups as described herein, unless otherwise indicated, are of the general formula C n H (2n+1-2x) where x is the number of double bonds present in the alkenyl group.
[0095] As used herein, the term "alkynyl" refers to any linear, branched, or cyclic hydrocarbon functional group containing one or more carbon-carbon triple bonds and containing in the range of 1 to 20 carbon atoms (i.e., C1-C 20 In some embodiments, an alkynyl group herein refers to any linear, branched, or cyclic hydrocarbon functional group containing one or more carbon-carbon triple bonds and containing in the range of 6 to 18 carbon atoms (i.e., C6-C 18 In other embodiments, an alkynyl group herein can include any linear, branched, or cyclic hydrocarbon functional group containing one or more carbon-carbon triple bonds and containing in the range of 10 to 16 carbon atoms (i.e., C6 to C8). 18 alkynyl).
[0096] As used herein, the term “heteroalkyl” refers to any linear, branched, or cyclic hydrocarbon functional group (i.e., C1-C6) containing in the range of 1 to 20 carbon atoms and one or more heteroatoms, including, but not limited to, N, O, P, S, Si, Se, and B, or any combination thereof. 20 In some embodiments, a heteroalkyl group in this application refers to any linear, branched, or cyclic hydrocarbon functional group (i.e., C6-C7) containing in the range of 6-18 carbon atoms and one or more heteroatoms, including, but not limited to, N, O, P, S, Si, Se, and B, or any combination thereof. 18 In other embodiments, the heteroalkyl group herein can be any linear, branched, or cyclic hydrocarbon functional group containing in the range of 10-16 carbon atoms and one or more heteroatoms, including, but not limited to, N, O, P, S, Si, Se, and B, or any combination thereof (i.e., C 10 ~C 16 In some embodiments, the heteroalkyl groups herein can have the general formula -RZ, -RZR, -ZRZR, or -RZRZR, where R is any of the same or different linear, branched, or cyclic C1-C 20 Z can contain one or more heteroatoms, including but not limited to, N, O, P, S, Si, Se, and B, or any combination thereof.
[0097] In some embodiments, heteroalkyl groups can include, but are not limited to, alkoxy groups, alkylamide groups, alkylthioether groups, alkylester groups, alkylsulfonate groups, alkylphosphate groups, etc. Examples of heteroalkyl groups suitable for use herein include -ROH, -RC(O)OH, -RC(O)OR, -ROR, -RSR, -RCHO, -RX, -RC(O)NH2, -RC(O)NR, RNH3 + , -RNH2, -RNO2, -RNHR, -RNRR, -RB(OH)2, -RSO3 - , -RPO4 2- or any combination thereof, but are not limited thereto. In the formula, R is any same or different linear, branched or cyclic C1-C 20 Alkyl, C1-C 20 Heteroalkyl (wherein at least one heteroatom is present in at least one R group, including but not limited to N, O, P, S, Si, Se, and B), or combinations thereof; X can be a halogen, including F, Cl, Br, I, or At.
[0098] As used herein, the term “heteroalkenyl” refers to any linear, branched, or cyclic hydrocarbon functional group containing one or more carbon-carbon double bonds and one or more heteroatoms, including, but not limited to, N, O, P, S, Si, Se, and B, or any combination thereof, and containing in the range of 1 to 20 carbon atoms (i.e., C1-C 20 In some embodiments, a heteroalkenyl group herein refers to any linear, branched, or cyclic hydrocarbon functional group containing one or more carbon-carbon double bonds and one or more heteroatoms, including, but not limited to, N, O, P, S, Si, Se, and B, or any combination thereof, and containing in the range of 6 to 18 carbon atoms (i.e., C6-C 18In other embodiments, the heteroalkenyl groups herein can include any linear, branched, or cyclic hydrocarbon functional group containing one or more carbon-carbon double bonds and one or more heteroatoms, including, but not limited to, N, O, P, S, Si, Se, and B, or any combination thereof, containing in the range of 10 to 16 carbon atoms (i.e., C 10 ~C 16 In some embodiments, the heteroalkenyl groups herein can have the general formula -RZ, -RZR, -ZRZR, or -RZRZR, where R is any of the same or different linear, branched, or cyclic C1-C 20 Alkyl or C1-C 20 alkenyl (provided that at least one carbon-carbon double bond is present in at least one R group), or combinations thereof; Z can contain one or more heteroatoms, including but not limited to N, O, P, S, Si, Se, and B, or any combinations thereof.
[0099] In some embodiments, heteroalkenyl groups can include, but are not limited to, alkenoxy groups, alkenylamines, alkenylthioester groups, alkenylester groups, alkenylsulfonate groups, alkenylphosphate groups, etc. Examples of heteroalkenyl groups suitable for use herein include -ROH, -RC(O)OH, -RC(O)OR, -ROR, -RSR, -RCHO, -RX, -RC(O)NH2, -RC(O)NR, RNH3 + , -RNH2, -RNO2, -RNHR, -RNRR, -RB(OH)2, -RSO3 - , -RPO4 2- or any combination thereof, but are not limited thereto. In the formula, R is any same or different linear, branched or cyclic C1-C 20 Alkyl or C1-C 20alkenyl (provided that at least one or more carbon-carbon double bonds and one or more heteroatoms, including but not limited to, N, O, P, S, Si, Se, and B, or combinations thereof, are present in at least one R group), or combinations thereof; X can be a halogen, including F, Cl, Br, I, or At.
[0100] As used herein, the term "heteroalkynyl" refers to any linear, branched or cyclic hydrocarbon functional group containing one or more carbon-carbon triple bonds and one or more heteroatoms, including, but not limited to, N, O, P, S, Si, Se, and B, or any combination thereof, and containing in the range of 1 to 20 carbon atoms (i.e., C1-C 20 In some embodiments, a heteroalkynyl group herein refers to any linear, branched, or cyclic hydrocarbon functional group containing one or more carbon-carbon triple bonds and one or more heteroatoms, including, but not limited to, N, O, P, S, Si, Se, and B, or any combination thereof, and containing in the range of 6 to 18 carbon atoms (i.e., C6-C 18 In other embodiments, the heteroalkynyl groups herein can include any linear, branched, or cyclic hydrocarbon functional group containing one or more carbon-carbon triple bonds and one or more heteroatoms, including, but not limited to, N, O, P, S, Si, Se, and B, or any combination thereof, and containing in the range of 10 to 16 carbon atoms (i.e., C 10 ~C 16 In some embodiments, the heteroalkynyl groups herein can have the general formula -RZ, -RZR, -ZRZR, or -RZRZR, where R is any of the same or different linear, branched, or cyclic C1-C 20 Alkyl, C1-C 20 Alkenyl or C1-C 20alkynyl (provided that at least one carbon-carbon triple bond is present in at least one R group), or combinations thereof; Z can contain one or more heteroatoms, including but not limited to N, O, P, S, Si, Se, and B, or any combinations thereof.
[0101] In some embodiments, heteroalkynyl groups can include, but are not limited to, alkynyloxy groups, alkynylamines, alkynylthioester groups, alkynylester groups, alkenylsulfonate groups, alkenylphosphate groups, etc. Examples of heteroalkynyl groups suitable for use herein include -ROH, -RC(O)OH, -RC(O)OR, -ROR, -RSR, -RCHO, -RX, -RC(O)NH2, -RC(O)NR, RNH3 + , -RNH2, -RNO2, -RNHR, -RNRR, -RB(OH)2, -RSO3 - , -RPO4 2- or any combination thereof, but are not limited thereto. In the formula, R is any same or different linear, branched or cyclic C1-C 20 Alkyl, C1-C 20 Alkenyl or C1-C 20 alkynyl (provided that at least one or more carbon-carbon triple bonds and one or more heteroatoms, including but not limited to, N, O, P, S, Si, Se, and B, or combinations thereof, are present in at least one R group), or combinations thereof; X can be a halogen, including F, Cl, Br, I, or At.
[0102] As used herein, the term “haloalkyl” refers to an alkyl group having in its amphibian form ... 20) containing any linear, branched or cyclic alkyl group (i.e., C1-C 20 In some embodiments, a haloalkyl group herein refers to any linear, branched, or cyclic alkyl group containing in the range of 6 to 18 carbon atoms (i.e., C6 to C8) in which one or more hydrogen atoms are replaced by a halogen atom, including at least one of F, Cl, Br, I, or At. 18 In other embodiments, the haloalkyl group herein can include any linear, branched, or cyclic alkyl group containing in the range of 10 to 16 carbon atoms (i.e., C) in which one or more hydrogen atoms are replaced by halogen atoms, including at least one of F, Cl, Br, I, or At. 10 ~C 16 In some embodiments, a haloalkyl can include a monohaloalkyl, which contains only one halogen atom in place of a hydrogen atom. In other embodiments, a haloalkyl can include a polyhaloalkyl, which contains two or more halogen atoms in place of a hydrogen atom, provided that at least one hydrogen atom remains. In still other embodiments, a haloalkyl can include a perhaloalkyl, which contains halogen atoms in place of all hydrogen atoms of the corresponding alkyl.
[0103] As used herein, the term “haloalkenyl” refers to an alkenyl group having in its amended form an alkyl ... 20 (i.e., C1-C5), where haloalkenyl groups contain at least one carbon-carbon double bond (i.e., C1-C5). 20haloalkenyl). In some embodiments, the haloalkenyl groups herein include any linear, branched, or cyclic alkenyl group containing in the range of 6 to 18 carbon atoms, in which one or more hydrogen atoms are replaced by a halogen atom, including at least one of F, Cl, Br, I, or At, and in which the haloalkenyl group contains at least one carbon-carbon double bond (i.e., C6 to C8). 18 In other embodiments, the haloalkenyl groups herein can include any linear, branched, or cyclic alkenyl group containing in the range of 10 to 16 carbon atoms, in which one or more hydrogen atoms are replaced by a halogen atom, including at least one of F, Cl, Br, I, or At, and in which the haloalkenyl group contains at least one carbon-carbon double bond (i.e., C 10 ~C 16 haloalkenyl).
[0104] As used herein, the term “haloalkynyl” refers to an alkynyl group having in its amended form an alkynyl group, in which one or more hydrogen atoms are replaced by halogen atoms, including at least one of F, Cl, Br, I, or At, and having in its amended form an alkynyl group ... 20 (i.e., C1-C5), where haloalkynyl groups contain at least one carbon-carbon triple bond (i.e., C1-C5). 20 Haloalkynyl). In some embodiments, the haloalkynyl groups herein include any linear, branched, or cyclic alkynyl group containing in the range of 6 to 18 carbon atoms, in which one or more hydrogen atoms are replaced by a halogen atom, including at least one of F, Cl, Br, I, or At, and in which the haloalkynyl group contains one or more carbon-carbon triple bonds (i.e., C6 to C8). 18In other embodiments, the haloalkynyl groups herein can include any linear, branched, or cyclic alkynyl group containing in the range of 10 to 16 carbon atoms, in which one or more hydrogen atoms are replaced by a halogen atom, including at least one of F, Cl, Br, I, or At, and in which the haloalkynyl group contains one or more carbon-carbon triple bonds (i.e., C 10 ~C 16 haloalkynyl).
[0105] As used herein, the term "halogenated heteroalkyl" refers to an alkyl group having in the range of 1 to 20 carbon atoms (i.e., C1 to C4 20 ), and one or more hydrogen atoms are replaced by halogen atoms, including at least one of F, Cl, Br, I, or At. 20 In some embodiments, the halogenated heteroalkyl groups herein refer to halogenated heteroalkyl groups having 6 to 18 carbon atoms (i.e., C6 to C8). 18 ), and one or more hydrogen atoms are replaced by halogen atoms, including at least one of F, Cl, Br, I, or At. 18 In other embodiments, the halogenated heteroalkyl groups herein can include any of a range of 10 to 16 carbon atoms (i.e., C 10 ~C 16 ), and in which one or more hydrogen atoms are replaced by halogen atoms, including at least one of F, Cl, Br, I, or At (i.e., C 10 ~C 16 ) halogenated heteroalkyl).
[0106] As used herein, the term "halogenated heteroalkenyl" refers to an alkyl group having in the range of 1 to 20 carbon atoms (i.e., C1 to C4 20), and one or more hydrogen atoms are replaced by halogen atoms, including at least one of F, Cl, Br, I, or At. 20 In some embodiments, the halogenated heteroalkenyl groups herein refer to halogenated heteroalkenyls having in the range of 6 to 18 carbon atoms (i.e., C6-C 18 ), and one or more hydrogen atoms are replaced by halogen atoms, including at least one of F, Cl, Br, I, or At. 18 In other embodiments, the halogenated heteroalkenyl groups herein can include any halogenated heteroalkenyl having 10 to 16 carbon atoms (i.e., C 10 ~C 16 ), and one or more hydrogen atoms are replaced by halogen atoms, including at least one of F, Cl, Br, I, or At (i.e., C 10 ~C 16 halogenated heteroalkenyl).
[0107] As used herein, the term "halogenated heteroalkynyl" refers to an alkynyl group having in the range of 1 to 20 carbon atoms (i.e., C1-C 20 Any heteroalkynyl group as described herein (i.e., C1-C6) containing one or more hydrogen atoms replaced by a halogen atom, including at least one of F, Cl, Br, I, or At. 20 In some embodiments, the halogenated heteroalkynyl groups herein refer to halogenated heteroalkynyl groups having in the range of 6 to 18 carbon atoms (i.e., C6-C 18 Any heteroalkynyl group as described herein (i.e., C6-C ... 18In other embodiments, the halogenated heteroalkynyl groups herein can include any halogenated heteroalkynyl group having in the range of 10 to 16 carbon atoms (i.e., C 10 ~C 16 ), and one or more hydrogen atoms are replaced by halogen atoms, including at least one of F, Cl, Br, I, or At (i.e., C 10 ~C 16 halogenated heteroalkynyl).
[0108] As used herein, the term "aryl" refers to any aromatic hydrocarbon functional group containing a C5-C8 membered aromatic ring, such as, for example, cyclopentadiene, benzene, and derivatives thereof. Aromatic radicals corresponding to the examples provided include, for example, cyclopentadienyl and phenyl radicals, and derivatives thereof. In some embodiments, the aryl functional groups herein can be further substituted to form substituted aryl functional groups. As used herein, the term "substituted aryl" refers to any aromatic hydrocarbon functional group containing a C5-C8 membered aromatic ring, which itself can be substituted with one or more alkyl, alkenyl, alkynyl, heteroalkyl, heteroalkenyl, or heteroalkynyl functional groups described herein, or any combination thereof.
[0109] In some embodiments, the aryl functional groups herein can include one or more heteroatoms to form a heteroaryl functional group. Heteroatoms suitable for use herein can include, but are not limited to, N, O, P, S, Si, Se, and B. As used herein, the term "heteroaryl" refers to any aryl functional group, as defined herein, in which one or more carbon atoms of a C5-C8 membered aromatic ring are replaced with one or more heteroatoms or combinations of heteroatoms. Examples of heteroaryl functional groups can include, but are not limited to, pyrrole, thiophene, furan, imidazole, pyridine, and pyrimidine radicals. The heteroaryl functional groups herein can be further substituted to form a substituted heteroaryl functional group. As used herein, the term "substituted heteroaryl" refers to any heteroaryl functional group, as defined herein, further substituted with one or more alkyl, alkenyl, alkynyl, heteroalkyl, heteroalkenyl, or heteroalkynyl functional groups, as described herein, or any combination thereof.
[0110] In some embodiments, the aryl functional groups herein can be further substituted to form an aryloxy functional group. As used herein, the term "aryloxy" can include a functional group of the general formula Aryl-O-, where the aryl functional group can include a C5-C8 membered aromatic ring. In some embodiments, the aryloxy group can include a phenoxy functional group of the formula C6H5O-. In some embodiments, the aryloxy functional group can be further substituted. As used herein, the term "substituted aryloxy" can include any aryloxy functional group as defined herein, further substituted with one or more alkyl functional groups, alkenyl functional groups, alkynyl functional groups, heteroalkyl functional groups, heteroalkenyl functional groups, or heteroalkynyl functional groups as described herein, or any combination thereof.
[0111] In some embodiments, the aryl functional groups herein can be further substituted to form an arylthio functional group. As used herein, the term "arylthio" can include a functional group of the general formula Aryl-S-, where the aryl functional group can include a C5-C8 membered aromatic ring. In some embodiments, the arylthio functional group can include a phenylsulfanyl functional group of the formula CHS-. In some embodiments, the arylthio functional group can be further substituted. As used herein, the term "substituted arylthio" can include any arylthio functional group defined herein, further substituted with one or more alkyl, alkenyl, alkynyl, heteroalkyl, heteroalkenyl, or heteroalkynyl functional groups as described herein, or any combination thereof.
[0112] In some embodiments, the aryl functional groups herein can be further substituted to form an arylamine functional group. As used herein, the term "arylamine" refers to a group having the general formula Aryl-NH n where the aryl functional group can include a C5-C8 membered aromatic ring and n can be 0-3, with the proviso that when n=0, 1, or 2, there is a non-H substitution at the N atom, which can include, but is not limited to, one or more alkyl, alkenyl, alkynyl, heteroalkyl, heteroalkenyl, or heteroalkynyl functional groups described herein, or any combination thereof.
[0113] In some embodiments, the arylamine functional group has the formula CHN 1-azanylbenzene functional group. In some embodiments, the arylamine functional group can be further substituted. As used herein, the term "substituted arylamine" can include any arylamine functional group as defined herein that is further substituted with one or more alkyl, alkenyl, alkynyl, heteroalkyl, heteroalkenyl or heteroalkynyl functional groups as described herein, or any combination thereof.
[0114] As used herein, the term "halogenated aryl" refers to any aromatic group containing a C5-C8 membered aromatic ring, such as, for example, cyclopentadiene, benzene, and derivatives thereof, or aromatic radicals corresponding to the examples provided, including, for example, cyclopentadienyl radicals and phenyl radicals and derivatives thereof, where one or more hydrogen atoms of the aryl group or corresponding aromatic radical are replaced by halogen atoms, including at least one of F, Cl, Br, I, or At, as described herein. In some embodiments, the halogenated aryl group can include a chlorophenyl group. In other embodiments, the halogenated aryl group can include a perfluorophenyl group.
[0115] In some embodiments, the halogenated aryl functional group herein can be further substituted to form a substituted halogenated aryl functional group. As used herein, the term "substituted halogenated aryl" refers to any halogenated aryl group described herein, which itself can be substituted with one or more alkyl functional groups, alkenyl functional groups, alkynyl functional groups, heteroalkyl functional groups, heteroalkenyl functional groups, heteroalkynyl functional groups, haloalkyl functional groups, haloalkenyl functional groups, haloalkynyl functional groups, halogenated heteroalkyl functional groups, halogenated heteroalkenyl functional groups, halogenated heteroalkynyl functional groups, or any combination thereof, as described herein.
[0116] As used herein, the term "biphenyl" refers to an aromatic hydrocarbon functional group having the molecular formula (CH) and, when attached to a porphyrin or metalloporphyrin, has one less hydrogen at the site of covalent attachment to the porphyrin or metalloporphyrin ring structure. In some embodiments, the biphenyl functional group can be substituted to form a substituted biphenyl functional group. As used herein, the term "substituted biphenyl" refers to a biphenyl functional group as described herein that is itself substituted with one or more alkyl, alkenyl, alkynyl, heteroalkyl, heteroalkenyl or heteroalkynyl functional groups as described herein, or any combination thereof.
[0117] Receptor molecules for the functionalization of graphene Receptor molecules suitable for functionalizing graphene can include any of the pyrarene, substituted pyrarene, calixarene, substituted calixarene, peralkylated cyclodextrin, substituted peralkylated cyclodextrin, pyrenes, or substituted pyrenes described herein.
[0118] Pillarene Pillarenes suitable for use herein include those that are substituted or unsubstituted. Pillarenes are a group of heterocyclic macrocycles with 5-15 modified hydroquinone subunits, each connected by a methylene (-CH2-) bridge. Without wishing to be bound by any particular theory, it is believed that the hydroquinone subunits of pyrarene form a symmetrical columnar structure that defines a central cavity. Pillarenes are a new class of macrocycles used in host-guest chemistry, as the central cavity can capture an analyte for chemical sensing purposes. Pillarenes can include those substituted at various positions on the benzene ring, including those that are 1,4-disubstituted, 1,2-disubstituted, or 1,5-disubstituted. The basic core structure of pyrarene is as follows: JPEG0007592070000016.jpg49170
[0119] In the formula, n is an integer of at least 5 to 15, and each R 0 are independent of each other, -R 1 , -OR 1 or -SR 1 Each R 1 are independently H; -OH; =O; any linear, branched or cyclic C1-C 20 Alkyl, C1-C 20 Alkenyl, C1-C 20 Alkynyl, C1-C 20 Heteroalkyl, C1-C 20 Heteroalkenyl, C1-C 20 Heteroalkynyl, C1-C 20 Haloalkyl, C1-C 20 Haloalkenyl, C1-C 20 Haloalkynyl, C1-C 20 Halogenated heteroalkyl, C1-C 20 Halogenated heteroalkenyl, C1-C 20 halogenated heteroalkynyl, or any combination thereof; aryl, heteroaryl, substituted aryl, substituted heteroarylaryl, aryl halide, substituted aryl halide, benzyl or substituted benzyl, biphenyl or substituted biphenyl, aryloxy, arylthio, arylamine, or any substituted form thereof; -R 2 OH, -R 2 C(O)OH, -R 2 C(O)OR 2 , -R 2 OR 2 , -R 2 S.R. 2 , -R 2 CHO, -R 2 X (wherein X is a halogen atom), -R 2 C(O)NH2, -R 2 C(O)NR 2 , -R 2 NH3 + , -R 2 NH2, -R 2 NO2, -R 2NHR 2 , -R 2 NR 2 R 2 , -R 2 N3, -R 2 OPO(OH)2, -R 2 Each R may include OSO(OH)2, or any derivative or combination thereof. 2 are independently any identical or different linear, branched or cyclic C1-C 20 Alkyl, C1-C 20 Alkenyl, C1-C 20 Alkynyl, C1-C 20 Heteroalkyl, C1-C 20 Heteroalkenyl, C1-C 20 Heteroalkynyl, C1-C 20 Haloalkyl, C1-C 20 Haloalkenyl, C1-C 20 Haloalkynyl, C1-C 20 Halogenated heteroalkyl groups, C1-C 20 Halogenated heteroalkenyl groups, C1-C 20 It may include halogenated heteroalkynyl groups, or any substitutions or combinations thereof.
[0120] In some embodiments, each R 1 can independently include any substitution, any derivative, or any combination of any of the foregoing. For example, -R 2 C(O)OH, -R 2 OPO(OH)2 and -R 2 It should be understood that in various embodiments where an acidic functional group is recited, such as OSO(OH), the corresponding sodium salts, potassium salts, etc. are also contemplated herein. 0 -R 1 In embodiments where R 1 can independently include -X, where X is any halogen atom, including at least one of F, Cl, Br, I, or At. In some embodiments, R 0 At least some of the substituents are other R 0In another embodiment, R 0 The substituents may all be the same.
[0121] In some embodiments, pillarenes suitable for use herein have the general formula: JPEG0007592070000017.jpg53170
[0122]
[0033] In the formula, each R 0 are independent of each other, -R 1 , -OR 1 or -SR 1 wherein x is an integer of at least 0 to 15, y is an integer of at least 0 to 15, and n is an integer of at least 5 to 15. 1 are independently H; -OH; =O; any linear, branched or cyclic C1-C 20 Alkyl, C1-C 20 Alkenyl, C1-C 20 Alkynyl, C1-C 20 Heteroalkyl, C1-C 20 Heteroalkenyl, C1-C 20 Heteroalkynyl, C1-C 20 Haloalkyl, C1-C 20 Haloalkenyl, C1-C 20 Haloalkynyl, C1-C 20 Halogenated heteroalkyl groups, C1-C 20 Halogenated heteroalkenyl groups, C1-C 20 a halogenated heteroalkynyl group, or any combination thereof; an aryl, a heteroaryl, a substituted aryl, a substituted heteroarylaryl, an aryl halide, a substituted aryl halide, a benzyl or substituted benzyl, a biphenyl or substituted biphenyl, an aryloxy, an arylthio, an arylamine, or any substituted form thereof; -R 2 OH, -R 2 C(O)OH, -R 2 C(O)OR 2 , -R 2 OR 2 , -R 2 S.R.2 , -R 2 CHO, -R 2 X (wherein X is a halogen atom), -R 2 C(O)NH2, -R 2 C(O)NR 2 , -R 2 NH3 + , -R 2 NH2, -R 2 NO2, -R 2 NHR 2 , -R 2 NR 2 R 2 , -R 2 N3, -R 2 OPO(OH)2, -R 2 Each R may include OSO(OH)2, or any derivative or combination thereof. 2 are independently any identical or different linear, branched or cyclic C1-C 20 Alkyl, C1-C 20 Alkenyl, C1-C 20 Alkynyl, C1-C 20 Heteroalkyl, C1-C 20 Heteroalkenyl, C1-C 20 Heteroalkynyl, C1-C 20 Haloalkyl, C1-C 20 Haloalkenyl, C1-C 20 Haloalkynyl, C1-C 20 Halogenated heteroalkyl groups, C1-C 20 Halogenated heteroalkenyl groups, C1-C 20 It may include halogenated heteroalkynyl groups, or any substitutions or combinations thereof.
[0123] In some embodiments, each R 1 can independently include any substitution, any derivative, or any combination of any of the foregoing. For example, -R 2 C(O)OH, -R 2 OPO(OH)2 and -R 2It should be understood that in various embodiments where an acidic functional group is recited, such as OSO(OH), the corresponding sodium salts, potassium salts, etc. are also contemplated herein. 0 -R 1 In embodiments where R 1 can independently include -X, where X is any halogen atom, including at least one of F, Cl, Br, I, or At. In some embodiments, R 0 At least some of the substituents are other R 0 In another embodiment, R 0 The substituents may all be the same.
[0124] In various embodiments, the pyrarenes suitable for use herein include pyrarenes such as dimethoxypyrra[5]arene or dimethoxypyrra[4]arene[1]quinone. In some embodiments, the pyrarenes suitable for use herein have the chemical structure: JPEG0007592070000018.jpg52170
[0125] Contains dimethoxypillar[5]arene. In other embodiments, pillarenes suitable for use herein have the chemical structure: JPEG0007592070000019.jpg47170
[0126] Contains dimethoxypillar[4]arene[1]quinone. Calixarene Calixarenes are a group of heterocyclic macrocycles with 3-15 aromatic moieties derived from compounds such as phenols, each connected by a substituted or unsubstituted methylene (-CH2-) bridge. Without wishing to be bound by any particular theory, it is believed that the subunits of calixarenes can form a cup-like shape that defines a central cavity. Calixarenes are a new class of macrocycles used in host-guest chemistry, as the central cavity can capture an analyte of interest for chemical sensing. Calixarenes suitable for use herein include those that are substituted or unsubstituted. Some exemplary structures of calixarenes are: JPEG0007592070000020.jpg60170
[0127] JPEG0007592070000021.jpg63170
[0128] and JPEG0007592070000022.jpg62170
[0129] wherein n is an integer of at least 3 to 15; and each R 0 are independent of each other, -R 1 , -OR 1 or -SR 1 Each R 1 are independently H; -OH; any linear, branched or cyclic C1-C 20 Alkyl, C1-C 20 Alkenyl, C1-C 20 Alkynyl, C1-C 20 Heteroalkyl, C1-C 20 Heteroalkenyl, C1-C 20 Heteroalkynyl, C1-C 20 Haloalkyl, C1-C 20 Haloalkenyl, C1-C 20 Haloalkynyl, C1-C 20 Halogenated heteroalkyl groups, C1-C 20 Halogenated heteroalkenyl groups, C1-C20 a halogenated heteroalkynyl group, or any combination thereof; an aryl, a heteroaryl, a substituted aryl, a substituted heteroarylaryl, an aryl halide, a substituted aryl halide, a benzyl or substituted benzyl, a biphenyl or substituted biphenyl, an aryloxy, an arylthio, an arylamine, or any substituted form thereof; -R 2 OH, -R 2 C(O)OH, -R 2 C(O)OR 2 , -R 2 OR 2 , -R 2 S.R. 2 , -R 2 CHO, -R 2 X (wherein X is a halogen atom), -R 2 C(O)NH2, -R 2 C(O)NR 2 , -R 2 NH3 + , -R 2 NH2, -R 2 NO2, -R 2 NHR 2 , -R 2 NR 2 R 2 , -R 2 N3, -R 2 OPO(OH)2, -R 2 Each R may include OSO(OH)2, or any derivative or combination thereof. 2 are independently any identical or different linear, branched or cyclic C1-C 20 Alkyl, C1-C 20 Alkenyl, C1-C 20 Alkynyl, C1-C 20 Heteroalkyl, C1-C 20 Heteroalkenyl, C1-C 20 Heteroalkynyl, C1-C 20 Haloalkyl, C1-C 20 Haloalkenyl, C1-C 20 Haloalkynyl, C1-C 20 Halogenated heteroalkyl groups, C1-C 20 Halogenated heteroalkenyl groups, C1-C20 It may include halogenated heteroalkynyl groups, or any substitutions or combinations thereof.
[0130] In some embodiments, each R 1 can independently include any substitution, any derivative, or any combination of any of the foregoing. For example, -R 2 C(O)OH, -R 2 OPO(OH)2 and -R 2 It should be understood that in various embodiments where an acidic functional group is recited, such as OSO(OH), the corresponding sodium salts, potassium salts, etc. are also contemplated herein. 0 -R 1 In embodiments where R 1 can independently include -X, where X is any halogen atom, including at least one of F, Cl, Br, I, or At. In some embodiments, R 0 At least some of the substituents are other R 0 In another embodiment, R 0 The substituents may all be the same.
[0131] Peralkylated Cyclodextrins A variety of peralkylated cyclodextrins may be suitable for use in modifying the surface of graphene as described herein. Peralkylated cyclodextrins suitable for use herein include those that are substituted or unsubstituted. In some embodiments, peralkylated cyclodextrins may include, but are not limited to, α-cyclodextrin, β-cyclodextrin, and γ-cyclodextrin, and derivatives thereof. In some embodiments, peralkylated cyclodextrins and derivatives thereof have the formula: JPEG0007592070000023.jpg44170
[0132] These may include, but are not limited to, those having In the formula, n can be any integer from 5 to 10 or any integer from 6 to 8, and Z can be -S or -O. 1 are independently H; any linear, branched or cyclic C1-C 20 Alkyl, C1-C 20 Alkenyl, C1-C 20 Alkynyl, C1-C 20 Heteroalkyl, C1-C 20 Heteroalkenyl, C1-C 20 Heteroalkynyl, C1-C 20 Haloalkyl, C1-C 20 Haloalkenyl, C1-C 20 Haloalkynyl, C1-C 20 Halogenated heteroalkyl groups, C1-C 20 Halogenated heteroalkenyl groups, C1-C 20 a halogenated heteroalkynyl group, or any combination thereof; an aryl, a heteroaryl, a substituted aryl, a substituted heteroarylaryl, an aryl halide, a substituted aryl halide, a benzyl or substituted benzyl, a biphenyl or substituted biphenyl, an aryloxy, an arylthio, or an arylamine; -R 2 OH, -R 2 C(O)OH, -R 2 C(O)OR 2 , -R 2 OR 2 , -R 2 S.R. 2 , -R 2 CHO, -R 2 X (wherein X is a halogen atom), -R 2 C(O)NH2, -R 2 C(O)NR 2 , -R 2 NH3 + , -R 2 NH2, -R 2 NO2, -R 2 NHR 2 , -R 2 NR 2 R 2 , -R 2 N3, -R 2 OPO(OH)2, -R 2Each R may include OSO(OH)2, or any derivative or combination thereof. 2 are independently any identical or different linear, branched or cyclic C1-C 20 Alkyl, C1-C 20 Alkenyl, C1-C 20 Alkynyl, C1-C 20 Heteroalkyl, C1-C 20 Heteroalkenyl, C1-C 20 Heteroalkynyl, C1-C 20 Haloalkyl, C1-C 20 Haloalkenyl, C1-C 20 Haloalkynyl, C1-C 20 Halogenated heteroalkyl groups, C1-C 20 Halogenated heteroalkenyl groups, C1-C 20 In some embodiments, each R 1 can independently include any substitution, any derivative, or any combination of any of the foregoing. In some embodiments, each R 1 can independently include any substitution, any derivative, or any combination of any of the foregoing.
[0133] For example -R 2 C(O)OH, -R 2 OPO(OH)2 and -R 2 In various embodiments where acidic functional groups such as OSO(OH)2 are recited, it should be understood that the corresponding sodium salts, potassium salts, etc. are also contemplated herein. In some embodiments, the presence of one or more hydroxyl or amino groups can contribute to hydrogen bonding between the cyclodextrin molecule and the graphene layer. In various embodiments, 1 may be replaced with -X, where X is any halogen atom including at least one of F, Cl, Br, I, or At.
[0134] In some embodiments, a peralkylated cyclodextrin suitable for use herein has the chemical structure: JPEG0007592070000024.jpg129170
[0135] Heptakis(2,3,6-tri-O-methyl)-β-cyclodextrin (referred to herein as "β-CDMe 21 "). Polycyclic aromatic hydrocarbons A variety of polycyclic aromatic hydrocarbon compounds may be suitable for use in modifying the surface of graphene as described herein. Polycyclic aromatic hydrocarbon compounds suitable for use herein include those that are substituted or unsubstituted. As described herein, polycyclic aromatic hydrocarbons have the formula: JPEG0007592070000025.jpg48170
[0136] It can be expressed by where n is an integer of at least 3 to 20, and each X is -R 1 , -OR 1 or -SR 1 Each R can be any substituent, including, but not limited to, 1 are independently -H, -OH, -C(O)OH, -C(O)OR 2 , -OR 2 , -SR 2 , -CHO, -X (wherein X is a halogen atom), -C(O)NH2, -C(O)NR 2 , -NH3 + , -NH2, -NO2, -NHR 2 , -NR 2 R 2 , -N3, -B(OH)2, -OPO(OH)2, -OSO(OH)2, any linear, branched or cyclic C1-C 20 Alkyl, C1-C 20 Alkenyl, C1-C 20 Alkynyl, C1-C 20 Heteroalkyl, C1-C 20 Heteroalkenyl, C1-C 20Heteroalkynyl, C1-C 20 Haloalkyl, C1-C 20 Haloalkenyl, C1-C 20 Haloalkynyl, C1-C 20 Halogenated heteroalkyl, C1-C 20 Halogenated heteroalkenyl, C1-C 20 halogenated heteroalkynyl, or any combination thereof; aryl, heteroaryl, substituted aryl, substituted heteroarylaryl, aryl halide, substituted aryl halide, benzyl or substituted benzyl, biphenyl or substituted biphenyl, aryloxy, arylthio, arylamine, or any substituted form thereof; -R 2 OH, -R 2 C(O)OH, -R 2 C(O)OR 2 , -R 2 OR 2 , -R 2 S.R. 2 , -R 2 CHO, -R 2 X (wherein X is a halogen atom), -R 2 C(O)NH2, -R 2 C(O)NR 2 , -R 2 NH3 + , -R 2 NH2, -R 2 NO2, -R 2 NHR 2 , -R 2 NR 2 R 2 , -R 2 N3, -R 2 B(OH)2, -R 2 OPO(OH)2, -R 2 Each R may include OSO(OH)2, or any derivative or combination thereof. 2 are independently any identical or different linear, branched or cyclic C1-C 20 Alkyl, C1-C 20 Alkenyl, C1-C 20 Alkynyl, C1-C 20 Heteroalkyl, C1-C 20 Heteroalkenyl, C1-C20 Heteroalkynyl, C1-C 20 Haloalkyl, C1-C 20 Haloalkenyl, C1-C 20 Haloalkynyl, C1-C 20 Halogenated heteroalkyl groups, C1-C 20 Halogenated heteroalkenyl groups, C1-C 20 It may include halogenated heteroalkynyl groups, or any substitutions or combinations thereof.
[0137] In some embodiments, each R 1 can independently include any substitution, any derivative, or any combination of any of the foregoing. For example, -R 2 B(OH)2, -R 2 C(O)OH, -R 2 OPO(OH)2 and -R 2 It should be understood that in various embodiments where an acidic functional group such as OSO(OH)2 is recited, the corresponding sodium salts, potassium salts, etc. are also contemplated herein. 1 In embodiments where R 1 can independently include -X, where X is any halogen atom including at least one of F, Cl, Br, I, or At.
[0138] In some embodiments, the polycyclic aromatic hydrocarbon has the formula: JPEG0007592070000026.jpg63170
[0139] Pyrene derivatives may include pyrenes, substituted pyrenes, and pyrene derivatives represented by In the formula, X is R 1 , -OR 1 or SR 1 Each R may be any substituent, including, but not limited to, 1 are independently -H, -OH, -C(O)OH, -C(O)OR 2 , -OR 2 , -SR 2, -CHO, -X (wherein X is a halogen atom), -C(O)NH2, -C(O)NR 2 , -NH3 + , -NH2, -NO2, -NHR 2 , -NR 2 R 2 , -N3, -B(OH)2, -OPO(OH)2, -OSO(OH)2, any linear, branched or cyclic C1-C 20 Alkyl, C1-C 20 Alkenyl, C1-C 20 Alkynyl, C1-C 20 Heteroalkyl, C1-C 20 Heteroalkenyl, C1-C 20 Heteroalkynyl, C1-C 20 Haloalkyl, C1-C 20 Haloalkenyl, C1-C 20 Haloalkynyl, C1-C 20 Halogenated heteroalkyl, C1-C 20 Halogenated heteroalkenyl, C1-C 20 halogenated heteroalkynyl, or any combination thereof; aryl, heteroaryl, substituted aryl, substituted heteroarylaryl, aryl halide, substituted aryl halide, benzyl or substituted benzyl, biphenyl or substituted biphenyl, aryloxy, arylthio, arylamine, or any substituted form thereof; -R 2 OH, -R 2 C(O)OH, -R 2 C(O)OR 2 , -R 2 OR 2 , -R 2 S.R. 2 , -R 2 CHO, -R 2 X (wherein X is a halogen atom), -R 2 C(O)NH2, -R 2 C(O)NR 2 , -R 2 NH3 + , -R 2 NH2, -R 2 NO2, -R 2 NHR 2 , -R 2 NR2 R 2 , -R 2 N3, -R 2 B(OH)2, -R 2 OPO(OH)2, -R 2 Each R may include OSO(OH)2, or any derivative or combination thereof. 2 are independently any identical or different linear, branched or cyclic C1-C 20 Alkyl, C1-C 20 Alkenyl, C1-C 20 Alkynyl, C1-C 20 Heteroalkyl, C1-C 20 Heteroalkenyl, C1-C 20 Heteroalkynyl, C1-C 20 Haloalkyl, C1-C 20 Haloalkenyl, C1-C 20 Haloalkynyl, C1-C 20 Halogenated heteroalkyl groups, C1-C 20 Halogenated heteroalkenyl groups, C1-C 20 It may include halogenated heteroalkynyl groups, or any substitutions or combinations thereof.
[0140] In some embodiments, each R 1 can independently include any substitution, any derivative, or any combination of any of the foregoing. For example, -R 2 B(OH)2, -R 2 C(O)OH, -R 2 OPO(OH)2 and -R 2 It should be understood that in various embodiments where an acidic functional group such as OSO(OH)2 is recited, the corresponding sodium salts, potassium salts, etc. are also contemplated herein. 1 In embodiments where R 1 can independently include -X, where X is any halogen atom including at least one of F, Cl, Br, I, or At.
[0141] In some embodiments, the polycyclic aromatic hydrocarbon has the formula pyrenyl-(CH2) n -SO3X, where n is a number from 0 to 10, and X is H or a metal cation, including, but not limited to, Na, K, Li, Rb, Cs, Mg, Ca, or Sr. As used herein, the term "pyrenyl" refers to a pyrene group.
[0142] In some embodiments, the polycyclic aromatic hydrocarbon has the formula: JPEG0007592070000027.jpg70170
[0143] The compound may include 1-pyrenesulfonic acid represented by: Langmuir adsorption theory Although not wishing to be bound by any particular theory, according to the Langmuir adsorption theory, monolayer modification of graphene is JPEG0007592070000028.jpg25170
[0144] can be controlled by varying the concentration of the adsorbate in the bulk of the self-assembly solution, according to where θ is the surface coverage, C is the concentration of the adsorbate in the bulk of the self-assembly solution, and K is the equilibrium constant for the adsorption of the adsorbate to graphene. Experimentally, the surface coverage is JPEG0007592070000029.jpg25170
[0145] can be expressed by the change in contact angle between unmodified and modified graphene according to where Φ(i) is the contact angle of the modified graphene as a function of the concentration of the self-assembly solution, Φ(bare) is the contact angle of unmodified graphene, and Φ(sat.) is the contact angle of graphene modified with a complete monolayer of receptor molecules (i.e., 100% surface coverage or θ=1.0), where the receptor molecules can include one or more of pillarene, substituted pillarene, calixarenes, substituted calixarenes, peralkylated cyclodextrins or substituted peralkylated cyclodextrins and derivatives thereof. Substituting θ from equation (2) into equation (1) and solving for Φ(i) gives equation (3). JPEG0007592070000030.jpg23170
[0146] Therefore, the experimentally observed Φ(i) values can be fitted as a function of the receptor concentration in the self-assembly solution using two fitting parameters, K and Φ(sat.). Once these two parameters are identified, the relative surface coverage at different self-assembly concentrations can be predicted from equation (1) using K.
[0147] The data can be fitted with a Langmuir adsorption model to determine the equilibrium constant for surface adsorption and the concentration of the self-assembly solution required to form a dense monolayer on graphene with 90% or greater surface coverage (i.e., θ>0.9). In some embodiments, a surface coverage of at least 90% or greater is desired. In some embodiments, a surface coverage of at least 95% or greater is desired. In some embodiments, a surface coverage of at least 98% or greater is desired.
[0148] Representative Langmuir adsorption isotherms for the adsorption of substituted pillararenes on graphene are shown in Figure 9 and are described more fully in Examples 1-3 below. The data show the relative monolayer coverage (dots) for the adsorption of dimethoxypillar[5]arene (herein "DMpillar[5]arene") on graphene as determined by XPS measurements, along with a fit (solid line) based on Langmuir adsorption theory. The relative surface coverage of DMpillar[5]arene adsorption on graphene as a function of the logarithm of the DMpillar[5]arene concentration in the self-assembly solution is shown in Figure 10.
[0149] In the above example, the Langmuir model is used to determine K from the elemental composition of the surfaces of unmodified and modified graphene obtained using X-ray photoelectron spectroscopy (XPS). Instead of using XPS data, data obtained by infrared or Raman spectroscopy or sessile drop contact angle measurements can also be used.
[0150] X-ray photoelectron spectroscopy X-ray photoelectron spectroscopy (XPS) is a sensitive spectroscopic technique that can quantitatively measure the elemental composition of a material's surface. The XPS process involves irradiating a surface with X-rays under vacuum while measuring the kinetic energy and emission of electrons within the top 0-10 nm of the material. Without wishing to be bound by any particular theory, it is believed that XPS can be used to confirm the presence of a self-assembled monolayer formed on the surface of graphene.
[0151] The surface concentrations of the atomic species that make up the monolayer, graphene and the underlying substrate (determined from XPS) depend on the Langmuir theta value of the monolayer, or in other words, the surface density of the monolayer molecules on the graphene. For example, the surface concentrations of carbon, oxygen and copper for a given monolayer of cyclodextrin on a copper substrate (i.e., C%, O% and Cu% determined from XPS) depend on the concentration of that cyclodextrin in the self-assembly solution. Fitting the C%, O% or Cu% data separately will result in slightly different values of the equilibrium constant of surface adsorption (K) due to experimental error. However, since the C%, O% or Cu% data characterize the same equilibrium, there is only one true value of K. Therefore, the XPS data can be fitted not only separately for the C%, O% and Cu% data, but also as one combined data set. Fitting the combined data for several atomic species that make up the monolayer, graphene and the underlying substrate will provide a more accurate estimate of the true value of K. For this purpose, the following formula can be used, where each data point consists of a vector containing (i) an index, (ii) the concentration of the self-assembly solution, and (iii) the concentration of carbon, oxygen or copper as determined by XPS: JPEG0007592070000031.jpg84170
[0152] Exponent 1 was used for the C% data, exponent 2 for the O% data, and exponent 3 for the Cu% data. The output of Kronecker delta for an input of 0 is 1, and for any other input it is 0. This fitting procedure gives the maximum surface concentrations of carbon, oxygen, and copper (i.e., C%(sat.), O%(sat.), and Cu%(sat.), respectively) in one step, along with a single value of K for all three adsorption isotherms.
[0153] In the above example, the K values are fitted from three adsorption isotherms, i.e., the surface concentrations of three types of atoms. The same type of fitting can be performed for the adsorption isotherms of 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 or more different types of atoms.
[0154] The equilibrium constant K determined by fitting the XPS data can be used in the Langmuir adsorption model to determine the θ value for graphene surfaces modified with various molecules that form monolayers on graphene, such as pillarene, substituted pillarenes, calixarenes, substituted calixarenes and their derivatives. Representative Langmuir adsorption isotherms for the adsorption of graphene modified with dimethoxypillar[5]arene are shown in Figure 9 and are described in more detail in Examples 1-3.
[0155] Droplet contact angle measurement method Sessile drop contact angle measurements can be used to determine the wettability of a solid surface by a liquid. Wettability or wetting can be due to intermolecular forces at the contact area between the liquid and the solid surface. The degree of wetting can be represented by the value of the contact angle Φ formed between the contact area between the liquid and the solid surface and a tangent to the liquid-air interface. If the solid surface is hydrophilic and water is used as the test liquid (i.e., high wettability), the value of Φ can be in the range of 0-90 degrees. If the solid surface is moderately hydrophilic to hydrophobic (i.e., moderate wettability), the value of Φ with water as the test liquid can be in the range of 85-105 degrees. If the solid surface is very hydrophobic (i.e., low wettability), the value of Φ with water as the test liquid can be in the range of 90-180 degrees. Thus, changes in the contact angle can reflect changes in the interfacial chemistry of the substrate.
[0156] Graphene surfaces and modifications made to the graphene surface can be characterized using sessile drop contact angle measurements. Sessile drop contact angle measurements can provide quantitative information on the extent of modification of the graphene surface. Contact angle measurements are sensitive to the functional groups present on the sample surface and can be used to identify the formation of self-assembled monolayers and the extent of surface coverage. The change in contact angle from an unmodified graphene surface compared to one immersed in a self-assembly solution containing pi-electron rich molecules can be used to confirm the formation of a self-assembled monolayer on the surface of graphene.
[0157] A suitable type of solvent for use in determining the contact angle measurements, also referred to as the wetting fluid, is one that maximizes the difference between the contact angle of the fluid on unmodified graphene and the contact angle on modified graphene, thereby improving data accuracy for measuring the bonding isotherm. In some embodiments, the wetting fluid can include, but is not limited to, deionized (DI) water, aqueous NaOH, borate buffer (pH 9.0), other pH buffers, CF3CH2OH, and the like. In some embodiments, the wetting fluid is polar. In some embodiments, the wetting fluid is non-polar.
[0158] method The pillarene, substituted pillarene, calixarenes, substituted calixarenes, peralkylated cyclodextrins, substituted peralkylated cyclodextrins, pyrenes, or substituted pyrenes herein may be used in one or more methods of modifying the surface of graphene. In one embodiment, the method may include forming a self-assembled monolayer, the self-assembled monolayer disposed on the outer surface of the graphene layer through non-covalent interactions between the self-assembled monolayer and the π-electron system of graphene. The method may include a self-assembled monolayer comprising one or more pillarenes, substituted pillarenes, calixarenes, or substituted calixarenes, or derivatives thereof, as described elsewhere herein. The method may include quantifying the degree of surface coverage of the self-assembled monolayer using sessile drop contact angle measurements, Raman spectroscopy, or X-ray photoelectron spectroscopy. In some embodiments, such non-covalent interactions may include electrostatic interactions. In other embodiments, the non-covalent interactions may include π-π stacking interactions.
[0159] In some embodiments, the method can further include selecting a derivatized graphene layer that exhibits a Langmuir theta value of at least 0.9, hi other embodiments, the method includes selecting a derivatized graphene layer that exhibits a Langmuir theta value of at least 0.98.
[0160] The pyrarene, substituted pyrarene, calixarenes, substituted calixarenes, peralkylated cyclodextrins, substituted peralkylated cyclodextrins, pyrenes or substituted pyrenes herein may be used in one or more methods of modifying a surface of graphene. In one embodiment, the method may include detecting an analyte. The method may include obtaining a gaseous sample from a patient and contacting the gaseous sample with one or more graphene varactors. The one or more graphene varactors may comprise a graphene layer and a self-assembled monolayer, the self-assembled monolayer being disposed on an outer surface of the graphene layer through non-covalent interactions between the self-assembled monolayer and the pi-electron system of graphene. The self-assembled monolayer may comprise at least one selected from the group comprising: pyrarene, substituted pyrarene, calixarene, substituted calixarene, peralkylated cyclodextrin, substituted peralkylated cyclodextrin, pyrenes or substituted pyrenes, or derivatives thereof, as described elsewhere herein. The method may further comprise measuring a differential response in an electrical property of the one or more graphene varactors due to binding of one or more analytes present in the gaseous sample, the electrical property may be selected from the group comprising: capacitance or resistance.
[0161] Aspects may be better understood with reference to the following examples, which are representative of certain embodiments, but do not limit the general scope of the embodiments herein. EXAMPLES
[0162] Example 1: Experimental Materials Dimethoxypillar[5]arene (herein "DMpillar[5]arene") was purchased from Tokyo Chemical Industry Co., Ltd. (Cambridge, MA). Monolayer graphene on Cu foil was purchased from Graphenea (Donostia, Spain). Heptakis(2,3,6-tri-O-methyl)-β-cyclodextrin (herein "β-CDMe21 "), hexane and acetonitrile were purchased from Sigma-Aldrich (St. Louis, MO). The chemical structure of DM pillar[5]arene is shown below. JPEG0007592070000032.jpg51170
[0163] β-CDMe 21 The chemical structure is as follows: JPEG0007592070000033.jpg113170
[0164] Example 2: Surface modification of graphene by self-assembly of DM pillar[5]arene Acetonitrile was used as the self-assembly solvent. The graphene substrate was immersed overnight in various concentrations of DM pillar[5]arene solutions, including 0 millimolar (mM), 0.0030 mM, 0.010 mM, 0.030 mM, 0.10 mM, or 0.30 mM. The graphene substrate modified with DM pillar[5]arene was then washed three times with a small amount of acetonitrile solvent to remove excess self-assembly solution.
[0165] Example 3: Surface characterization of graphene modified with DM pillar[5]arene X-ray photoelectron spectroscopy (XPS) spectra of unmodified graphene and graphene modified with DM pillar[5]arene were collected with a VersaProbe III scanning XPS microprobe (PHI5000, 5 Physical Electronics, Chanhassen, MN). The surface elemental composition results of graphene modified with DM pillar[5]arene are shown in Table 1.
[0166] [Table 1]
[0167] The C%, O%, and Cu% data were simultaneously fitted as described above to determine the equilibrium constant, K. The equilibrium constant, K, and the concentration of the self-assembly solution required to form at least a 90% monolayer with DM-pillar[5]arene are shown in Table 2.
[0168] [Table 2]
[0169] The Langmuir adsorption isotherms for the adsorption of DMpillar[5]arene-modified graphene are shown in Figure 9. The figure shows the relative monolayer coverage (dots) for the adsorption of DMpillar[5]arene-modified graphene as determined by XPS data, together with a fit based on the Langmuir adsorption theory (solid line). The relative surface coverage of DMpillar[5]arene adsorption on graphene as a function of the logarithm of the DMpillar[5]arene concentration in the self-assembly solution is shown in Figure 10.
[0170] Example 4: β-CDMe 21 Surface modification of graphene by self-organization of Hexane was used as the self-assembly solvent. The graphene substrate was coated with various concentrations of β-CDMe, including 0 millimolar (mM), 0.0050 mM, 0.010 mM, 0.050 mM, 0.10 mM, or 0.50 mM. 21 The sample was then soaked in the solution overnight. 21 The graphene substrate modified with was washed three times with a small amount of hexane solvent to remove the excess self-assembly solution.
[0171] Example 5: β-CDMe 21 Surface characterization of graphene decorated with Unmodified graphene and β-CDMe 21 X-ray photoelectron spectroscopy (XPS) spectra of graphene modified with β-CDMe were collected on a Versaprobe III scanning XPS microprobe (PHI5000, 5 Physical Electronics, Chanhassen, MN). 21The results of the surface elemental composition of graphene modified with are shown in Table 3.
[0172] [Table 3]
[0173] The C%, O% and Cu% data were simultaneously fitted as described above to determine the equilibrium constant K. The equilibrium constant K and β-CDMe 21 The concentrations of the self-assembly solutions required for the formation of at least a 90% monolayer by .alpha. are shown in Table 4.
[0174] [Table 4]
[0175] β-CDMe 21 The Langmuir adsorption isotherms for the adsorption of graphene modified with β-CDMe are shown in Figure 11. The figure shows that the adsorption of β-CDMe was determined by XPS data. 21 The relative monolayer coverage (dots) for the adsorption of graphene modified with β-CDMe is shown along with a fit based on the Langmuir adsorption theory (solid line). 21 β-CDMe on graphene as a function of the logarithm of the concentration 21 The relative surface coverage of the adsorption is shown in FIG.
[0176] It should be noted that as used in this specification and the appended claims, the singular forms "a," "an," and "the" include plural referents unless the content clearly dictates otherwise. It should also be noted that the term "or" is generally used in its sense including "and / or" unless the content clearly dictates otherwise.
[0177] It should also be noted that, as used in this specification and the appended claims, the phrase "configured to" describes a system, apparatus, or other structure that is constructed or configured to perform a particular task or assume a particular configuration. The phrase "configured to" may be used interchangeably with other similar phrases, such as configured to be arranged, constructed and arranged, constructed, manufactured, and arranged.
[0178] All publications and patent applications in this specification are indicative of the general state of the art to which this invention pertains. All publications and patent applications are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be a reference.
[0179] As used herein, the recitation of numerical ranges by endpoints is intended to include all numbers subsumed within that range (eg, 2 to 8 includes 2.1, 2.8, 5.3, 7, etc.).
[0180] The headings used herein are provided to be consistent with the suggestions under 37 CFR § 1.77 or to otherwise provide organizational guidance. These headings should not be considered to limit or characterize the inventions described in any claims that may be filed from this disclosure. By way of example, even if a heading refers to a "field," such claims should not be limited by the language selected under this heading to describe the so-called technical field. Furthermore, the description of a technology in the "background" is not an admission that the technology is prior art to any invention in this disclosure. The "summary" is also not considered to characterize the inventions described in the claims that are filed.
[0181] The embodiments described herein are not intended to be exhaustive or to limit the invention to the precise forms disclosed in the following detailed description. Rather, the embodiments are chosen and described so that those skilled in the art can appreciate and understand the principles and practices. Thus, aspects have been described with reference to various specific preferred embodiments and techniques. However, it should be understood that many modifications and variations can be made while remaining within the spirit and scope of the description.
Claims
1. 1. A medical device for detecting volatile organic compounds in a gaseous breath sample, comprising: a graphene varactor; and a sensor for measuring an electrical property of the graphene varactor, the graphene varactor comprising: A graphene layer; a self-assembled monolayer disposed on an outer surface of the graphene layer through non-covalent interactions between the self-assembled monolayer and the π-electron system of graphene; The medical device, wherein the self-assembled monolayer comprises one or more pillararenes, substituted pillararenes, calixarenes, or substituted calixarenes.
2. 10. The medical device of claim 1, wherein the self-assembled monolayer provides a Langmuir theta value of at least 0.
9.
3. 3. The medical device of claim 1 or 2, wherein the self-assembled monolayer provides a coverage on the graphene of between 50% and 150% by surface area.
4. The self-assembled monolayer is and a substituted pillararene having the formula: Each R 0 are independently -R 1 , -OR 1 Or -SR 1 may include Each R 1 are independently H; -OH; =O; any linear, branched or cyclic C 1 ~C 20 Alkyl, C 1 ~C 20 Alkenyl, C 1 ~C 20 Alkynyl, C 1 ~C 20 Heteroalkyl, C 1 ~C 20 Heteroalkenyl, C 1 ~C 20 Heteroalkynyl, C 1 ~C 20 Haloalkyl group, C 1 ~C 20 Haloalkenyl group, C 1 ~C 20 Haloalkynyl group, C 1 ~C 20 Halogenated heteroalkyl groups, C 1 ~C 20 Halogenated heteroalkenyl groups, C 1 ~C 20 a halogenated heteroalkynyl group, or any combination thereof; an aryl, a heteroaryl, a substituted aryl, a substituted heteroarylaryl, an aryl halide, a substituted aryl halide, a benzyl or substituted benzyl, a biphenyl or substituted biphenyl, an aryloxy, an arylthio, an arylamine, or any substituted form thereof; -R 2 OH, -R 2 C(O)OH, -R 2 C(O)OR 2 , -R 2 OR 2 , -R 2 S.R. 2 , -R 2 CHO, -R 2 X (wherein X is a halogen atom), -R 2 C(O)NH 2 , -R 2 C(O)NR 2 , -R 2 N.H. 3 + , -R 2 N.H. 2 , -R 2 NO 2 , -R 2 NHR 2 , -R 2 N.R. 2 R 2 , -R 2 N 3 , -R 2 OPO (OH) 2 , -R 2 OSO(OH) 2 or any derivative or combination thereof, Each R 2 are independently any identical or different linear, branched or cyclic C 1 ~C 20 Alkyl, C 1 ~C 20 Alkenyl, C 1 ~C 20 Alkynyl, C 1 ~C 20 Heteroalkyl, C 1 ~C 20 Heteroalkenyl, C 1 ~C 20 Heteroalkynyl, C 1 ~C 20 Haloalkyl group, C 1 ~C 20 Haloalkenyl group, C 1 ~C 20 Haloalkynyl group, C 1 ~C 20 Halogenated heteroalkyl groups, C 1 ~C 20 Halogenated heteroalkenyl groups, C 1 ~C 20 halogenated heteroalkynyl groups, or any substitution or combination thereof; The medical device according to any one of claims 1 to 3, wherein n is an integer of at least 5 to 15.
5. The self-assembled monolayer is and a substituted pillararene having the formula: Each R 0 are independently -R 1 , -OR 1 Or -SR 1 may include Each R 1 are independently H; -OH; =O; any linear, branched or cyclic C 1 ~C 20 Alkyl, C 1 ~C 20 Alkenyl, C 1 ~C 20 Alkynyl, C 1 ~C 20 Heteroalkyl, C 1 ~C 20 Heteroalkenyl, C 1 ~C 20 Heteroalkynyl, C 1 ~C 20 Haloalkyl group, C 1 ~C 20 Haloalkenyl group, C 1 ~C 20 Haloalkynyl group, C 1 ~C 20 Halogenated heteroalkyl groups, C 1 ~C 20 Halogenated heteroalkenyl groups, C 1 ~C 20 a halogenated heteroalkynyl group, or any combination thereof; an aryl, a heteroaryl, a substituted aryl, a substituted heteroarylaryl, an aryl halide, a substituted aryl halide, a benzyl or substituted benzyl, a biphenyl or substituted biphenyl, an aryloxy, an arylthio, an arylamine, or any substituted form thereof; -R 2 OH, -R 2 C(O)OH, -R 2 C(O)OR 2 , -R 2 OR 2 , -R 2 S.R. 2 , -R 2 CHO, -R 2 X (wherein X is a halogen atom), -R 2 C(O)NH 2 , -R 2 C(O)NR 2 , -R 2 N.H. 3 + , -R 2 N.H. 2 , -R 2 NO 2 , -R 2 NHR 2 , -R 2 N.R. 2 R 2 , -R 2 N 3 , -R 2 OPO (OH) 2 , -R 2 OSO(OH) 2 or any derivative or combination thereof, Each R 2 are independently any identical or different linear, branched or cyclic C 1 ~C 20 Alkyl, C 1 ~C 20 Alkenyl, C 1 ~C 20 Alkynyl, C 1 ~C 20 Heteroalkyl, C 1 ~C 20 Heteroalkenyl, C 1 ~C 20 Heteroalkynyl, C 1 ~C 20 Haloalkyl group, C 1 ~C 20 Haloalkenyl group, C 1 ~C 20 Haloalkynyl group, C 1 ~C 20 Halogenated heteroalkyl groups, C 1 ~C 20 Halogenated heteroalkenyl groups, C 1 ~C 20 halogenated heteroalkynyl groups, or any substitution or combination thereof; The medical device according to any one of claims 1 to 4, wherein x is an integer of at least 0 to 15, y is an integer of at least 0 to 15, and n is an integer of at least 5 to 15.
6. The self-assembled monolayer is or and a substituted calixarene having any one of the following formulas: Each R 0 are independently -R 1 , -OR 1 Or -SR 1 may include Each R 1 are independently H; -OH; any linear, branched or cyclic C 1 ~C 20 Alkyl, C 1 ~C 20 Alkenyl, C 1 ~C 20 Alkynyl, C 1 ~C 20 Heteroalkyl, C 1 ~C 20 Heteroalkenyl, C 1 ~C 20 Heteroalkynyl, C 1 ~C 20 Haloalkyl group, C 1 ~C 20 Haloalkenyl group, C 1 ~C 20 Haloalkynyl group, C 1 ~C 20 Halogenated heteroalkyl groups, C 1 ~C 20 Halogenated heteroalkenyl groups, C 1 ~C 20 a halogenated heteroalkynyl group, or any combination thereof; an aryl, a heteroaryl, a substituted aryl, a substituted heteroarylaryl, an aryl halide, a substituted aryl halide, a biphenyl or a substituted biphenyl, an aryloxy, an arylthio, an arylamine, or any substitution thereof; -R 2 OH, -R 2 C(O)OH, -R 2 C(O)OR 2 , -R 2 OR 2 , -R 2 S.R. 2 , -R 2 CHO, -R 2 X (wherein X is a halogen atom), -R 2 C(O)NH 2 , -R 2 C(O)NR 2 , -R 2 N.H. 3 + , -R 2 N.H. 2 , -R 2 NO 2 , -R 2 NHR 2 , -R 2 N.R. 2 R 2 , -R 2 N 3 , -R 2 OPO (OH) 2 , -R 2 OSO(OH) 2 or any derivative or combination thereof, Each R 2 are independently any identical or different linear, branched or cyclic C 1 ~C 20 Alkyl, C 1 ~C 20 Alkenyl, C 1 ~C 20 Alkynyl, C 1 ~C 20 Heteroalkyl, C 1 ~C 20 Heteroalkenyl, C 1 ~C 20 Heteroalkynyl, C 1 ~C 20 Haloalkyl group, C 1 ~C 20 Haloalkenyl group, C 1 ~C 20 Haloalkynyl group, C 1 ~C 20 Halogenated heteroalkyl groups, C 1 ~C 20 Halogenated heteroalkenyl groups, C 1 ~C 20 halogenated heteroalkynyl groups, or any substitution or combination thereof; The medical device according to any one of claims 1 to 5, wherein n is an integer of at least 3 to 15.
7. 1. A method for modifying a surface of graphene, the method comprising: forming a self-assembled monolayer; and quantifying the degree of surface coverage of the self-assembled monolayer using sessile drop contact angle measurements, Raman spectroscopy, or X-ray photoelectron spectroscopy; the self-assembled monolayer is disposed on an outer surface of the graphene layer through non-covalent interactions between the self-assembled monolayer and the π electron system of graphene; the self-assembled monolayer comprises one or more pillararenes, substituted pillararenes, calixarenes, or substituted calixarenes; A method, wherein the surface of modified graphene is configured to detect volatile organic compounds in a gaseous breath sample.
8. 8. The method of claim 7, further comprising selecting a derivatized graphene layer that exhibits a Langmuir theta value of at least 0.
9.
9. The self-assembled monolayer is and a substituted pillararene having the formula: Each R 0 are independently -R 1 , -OR 1 Or -SR 1 may include Each R 1 are independently H; -OH; =O; any linear, branched or cyclic C 1 ~C 20 Alkyl, C 1 ~C 20 Alkenyl, C 1 ~C 20 Alkynyl, C 1 ~C 20 Heteroalkyl, C 1 ~C 20 Heteroalkenyl, C 1 ~C 20 Heteroalkynyl, C 1 ~C 20 Haloalkyl group, C 1 ~C 20 Haloalkenyl group, C 1 ~C 20 Haloalkynyl group, C 1 ~C 20 Halogenated heteroalkyl groups, C 1 ~C 20 Halogenated heteroalkenyl groups, C 1 ~C 20 a halogenated heteroalkynyl group, or any combination thereof; an aryl, a heteroaryl, a substituted aryl, a substituted heteroarylaryl, an aryl halide, a substituted aryl halide, a benzyl or substituted benzyl, a biphenyl or substituted biphenyl, an aryloxy, an arylthio, an arylamine, or any substituted form thereof; -R 2 OH, -R 2 C(O)OH, -R 2 C(O)OR 2 , -R 2 OR 2 , -R 2 S.R. 2 , -R 2 CHO, -R 2 X (wherein X is a halogen atom), -R 2 C(O)NH 2 , -R 2 C(O)NR 2 , -R 2 N.H. 3 + , -R 2 N.H. 2 , -R 2 NO 2 , -R 2 NHR 2 , -R 2 N.R. 2 R 2 , -R 2 N 3 , -R 2 OPO (OH) 2 , -R 2 OSO(OH) 2 or any derivative or combination thereof, Each R 2 are independently any identical or different linear, branched or cyclic C 1 ~C 20 Alkyl, C 1 ~C 20 Alkenyl, C 1 ~C 20 Alkynyl, C 1 ~C 20 Heteroalkyl, C 1 ~C 20 Heteroalkenyl, C 1 ~C 20 Heteroalkynyl, C 1 ~C 20 Haloalkyl group, C 1 ~C 20 Haloalkenyl group, C 1 ~C 20 Haloalkynyl group, C 1 ~C 20 Halogenated heteroalkyl groups, C 1 ~C 20 Halogenated heteroalkenyl groups, C 1 ~C 20 halogenated heteroalkynyl groups, or any substitution or combination thereof; The method of claim 7 or 8, wherein n is an integer of at least 5 to 15.
10. The self-assembled monolayer is and a substituted pillararene having the formula: Each R 0 are independently -R 1 , -OR 1 Or -SR 1 may include Each R 1 are independently H; -OH; any linear, branched or cyclic C 1 ~C 20 Alkyl, C 1 ~C 20 Alkenyl, C 1 ~C 20 Alkynyl, C 1 ~C 20 Heteroalkyl, C 1 ~C 20 Heteroalkenyl, C 1 ~C 20 Heteroalkynyl, C 1 ~C 20 Haloalkyl group, C 1 ~C 20 Haloalkenyl group, C 1 ~C 20 Haloalkynyl group, C 1 ~C 20 Halogenated heteroalkyl groups, C 1 ~C 20 Halogenated heteroalkenyl groups, C 1 ~C 20 a halogenated heteroalkynyl group, or any combination thereof; an aryl, a heteroaryl, a substituted aryl, a substituted heteroarylaryl, an aryl halide, a substituted aryl halide, a benzyl or substituted benzyl, a biphenyl or substituted biphenyl, an aryloxy, an arylthio, an arylamine, or any substituted form thereof; -R 2 OH, -R 2 C(O)OH, -R 2 C(O)OR 2 , -R 2 OR 2 , -R 2 S.R. 2 , -R 2 CHO, -R 2 X (wherein X is a halogen atom), -R 2 C(O)NH 2 , -R 2 C(O)NR 2 , -R 2 N.H. 3 + , -R 2 N.H. 2 , -R 2 NO 2 , -R 2 NHR 2 , -R 2 N.R. 2 R 2 , -R 2 N 3 , -R 2 OPO (OH) 2 , -R 2 OSO(OH) 2 or any derivative or combination thereof, Each R 2 are independently any identical or different linear, branched or cyclic C 1 ~C 20 Alkyl, C 1 ~C 20 Alkenyl, C 1 ~C 20 Alkynyl, C 1 ~C 20 Heteroalkyl, C 1 ~C 20 Heteroalkenyl, C 1 ~C 20 Heteroalkynyl, C 1 ~C 20 Haloalkyl group, C 1 ~C 20 Haloalkenyl group, C 1 ~C 20 Haloalkynyl group, C 1 ~C 20 Halogenated heteroalkyl groups, C 1 ~C 20 Halogenated heteroalkenyl groups, C 1 ~C 20 halogenated heteroalkynyl groups, or any substitution or combination thereof; 10. The method of any one of claims 7 to 9, wherein x is an integer of at least 0 to 15, y is an integer of at least 0 to 15, and n is an integer of at least 5 to 15.
11. A method for detecting one or more volatile organic compounds, comprising: Obtaining a gaseous sample from a patient; and contacting the gaseous sample with one or more graphene varactors, each of the one or more graphene varactors comprising: A graphene layer; a self-assembled monolayer disposed on an outer surface of the graphene layer through non-covalent interactions between the self-assembled monolayer and the π-electron system of graphene; The method of claim 1, wherein the self-assembled monolayer comprises at least one selected from the group consisting of pillararenes, substituted pillararenes, calixarenes, or substituted calixarenes.
12. 12. The method of claim 11, further comprising measuring a differential response in electrical properties of the one or more graphene varactors due to binding of the one or more volatile organic compounds present in the gaseous sample.
Citation Information
Patent Citations
Systems and methods for analyte sensing in physiological gas samples
JP2019020415A
JPP7073537B
Modified graphene structures and methods of manufacture thereof
US20120058350A1
Device for Measurement of Exhaled Nitric Oxide Concentration
US20150338390A1
Device for measurement of exhaled ethanol concentration
US9011779B1
